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ABSTRACT
Androgen Effects on Food Intake, Body Weight
and Carcass Composition in Male Rats
(September, 1981)
Linda Irene Siegel, B.A.
, University of Wisconsin
M.S., University of Massachusetts
Ph.D., University of Massachusetts
Directed by: Professor George Wade
Long-term treatment with low doses (0.2 mg/day)
of the aromatizable androgen, testosterone propionate
(TP)
, increased food intake and body weight gain in
gonadectomized (GDX) , adult male rats. Dietary self-
selection studies revealed that the increased intake
was due to enhanced consumption of all dietary com-
ponents. Prolonged treatment with higher doses of TP
(2.0 mg/day) reduced weight gain compared to the lower
dose of TP, and increased protein, but not carbohydrate
intake, and reduced carcass fat. The elevated protein
intakes of both TP-treated groups were associated with
increased carcass protein contents.
The nonaromatizable androgen, 5a-dihydrotestos-
terone propionate (DHTP; 0.2 or 2.0 mg/day), also
increased protein (but not carbohydrate) intake and
weight gain in GDX male rats, but it did not alter
carcass composition. Unlike TP, both doses of DHTP were
equally effective, but neither dose of DHTP was as
V
effective as the low dose of TP in stimulating protein
and carbohydrate intake and body weight gain.
The results of these experiments suggest:
1) Androgens can increase selection of dietary protein
whether or not they exert significant protein anabolic
effects. 2) The 5a-reduced metabolite of testosterone,
5a-dihydrotestosterone, is not the major metabolite
responsible for the increases in protein and caloric
intake and in body weight caused by TP. 3) The decreases
in carbohydrate intake and adiposity in rats given the
high dose of TP may be mediated by aromatized (estro-
genic) metabolites of the androgen.
Further support for the hypothesis that high doses
of TP decrease weight gain and adiposity via estrogenic
metabolites is provided by the finding that concurrent
treatment with androsta-1 , 4 , 6-tr iene-3 , 17-dione (ATD)
,
which blocks aromatization of androgens to estrogens,
prevented the weight-reducing effects of high doses of
TP. Furthermore, prolonged treatment with 1.0 mg TP/day
also depleted cytoplasmic estrogen receptors and reduced
lipoprotein lipase (LPL) activity in epididymal adipose
tissue in GDX males (similar changes follow estrogen
treatment in female rats) . Both effects were blocked by
concurrent treatment with ATD. These results suggest
that estrogenic androgen metabolites may reduce weight
vi
by direct actions on adipose tissue metabolism.
Copulation has been shown to increase testosterone
levels in male rats. Mated male rats decreased body
weight, but this decrease was not associated with
changes in caloric intake or intake of specific nutri-
ents; nor was LPL activity affected by sexual activity.
Thus, copulation-induced reductions in weight may be
mediated by mechanisms other than those cited above for
rats receiving high doses of TP.
In addition to peripheral effects, testosterone
or its estrogenic metabolites may also act on central
sites to influence eating. Implants of TP in the
ventromedial hypothalamus (VMH) reduced food intake in
GDX males. Implants of TP in the anterior hypothalamus-
preoptic area or VMH implants of DHTP did not alter food
intake.
Finally, a single injection of estradiol has been
shown to decrease food intake in castrated rats fed a
high fat diet, but this treatment has no effect on in-
take in GDX males fed a chow diet. It was hypothesized
that if high doses of TP affect food intake, in part,
via estrogenic metabolites, then GDX male rats fed a high
fat diet and given high doses of TP should eat less than
similarly treated rats fed chow. No evidence was found
vii
to support this hypothesis. Rats in both diet gro
responded similarly to TP treatment.
viii
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CHAPTER I
INTRODUCTION
In many mammalian species, including man, the male
of the species is heavier than the female (Slob and
van der Werff ten Bosch, 1975; Tanner, 1962), although
exceptions do occur (e.g., female hyenas, hamsters and
Saguinus New World monkeys are larger than their male
counterparts; Hoyenga and Hoyenga, 1979). Adult male
rats are longer and heavier, and eat more than do sim-
ilarly aged females (King, 1915; Wang, 1924). The sex
differences in food intake and body weight in rats can
be attributed largely to the influences of gonadal
hormones (for reviews, see Wade, 1975; 1976; Wade and
Gray, 1979) .
Mechanism of Action of Steroids
All steroid hormones are believed to have a common
mode of action (for reviews, see Gorski and Gannon, 1976;
Mainwaring, 1977). Steroids are transported in the blood
in the form of stable complexes with plasma proteins.
The hormones enter all cells, purportedly by the process
of passive diffusion (although specific transport mech-
anisms have been proposed; Mainwaring, 1977) . Within
target cells (such as those in uterus and hypothalamus)
1
2the steroids bind with steroid specificity and high
affinity to cytoplasmic receptor proteins. Changes in
the configurations of the hormone-receptor complexes
occur, resulting in activated complexes. These activated
hormone-receptor complexes are translocated into cell
nuclei where they are retained at sites in chromatin,
causing changes in RNA synthesis which result in altered
protein synthesis.
Many steroids exert their effects without chemical
modification. However, some hormones, primarily the
androgens, are subject to extensive metabolism within
target cells prior to binding to cytoplasmic receptors.
For example, testosterone is rapidly metabolized by
5a-reductase to 5a-dihydrotestosterone (DHT) in many
peripheral tissues (e.g., prostate, seminal vesicles and
epididymis) ; and it is DHT that binds to the androgen
receptor and subsequently produces the tissue-specific
response (Liang, Tymoczko, Chan, Hung and Liao, 1977).
Testosterone and certain other steroids of the 19-carbon
series can also be converted (aromatized) to estrogens by
the aromatase enzyme system in some peripheral tissues
(Mainwaring, 1977). In the central nervous system,
enzymes associated with both 5a-reduction and aromatiza-
tion have been identified, and they are primarily con-
centrated in the hypothalamus and amygdala (Celotti,
3Massa and Martini, 1979; Goy and McEwen, 1980).
Historically, the growth-promoting influences of
hormones such as DHT on the male reproductive tract
have been termed androgenic effects. Testosterone and
some of its metabolites also stimulate growth in non-
reproductive tissues such as skeletal muscle, kidney
and liver. The effects of androgens on these tissues
are associated with decreased urinary nitrogen excretion
(indicating enhanced protein synthesis), and are referred
to as anabolic actions.
Gonadal Hormone Effects on Food Intake and Body Weight
The practice of ablative surgery on the male
reproductive glands appears to date back to earliest
recorded history. The first scientific investigation of
the effects of castration may have been performed by
Aristotle, who recorded the effects of removal of the
gonads in the cockerel and compared them with changes
observed in castrated men (Mainwaring, 1977; Turner and
Bagnara, 1971) . Although orchiectomy is an ancient
practice, surprisingly little is known about the effects
of this procedure on body weight and food intake. Ad-
mittedly, purified testicular hormones were not readily
available for use in hormone replacement studies prior
to the isolation of testosterone by David and colleagues
4in 1935 (although there is evidence that alchemists of
ancient Cathay isolated and purified steroid hormones;
Mainwaring, 1977). In the mid 1930's to the mid
1940's, Kochakian used fat-soluble extracts from male
urine to investigate the effects of androgens on nitrogen
metabolism and body weight in castrated dogs. He later
extended his studies to include the effects of testos-
terone on nitrogen balance in rats (Kochakian, 1975) .
Yet it was not until 1976 that the effects of two andro-
gens on food intake in rats were unequivocally estab-
lished (Gentry and Wade, 1976a).
In contrast, a comparatively vast amount of
information is available on the effects of ovariectomy
and ovarian hormone replacement on food intake, body
weight and adiposity in female rats (Wade, 1975; 1976;
Wade and Gray, 1979) . Because some of the effects of
particular testicular hormones on the above parameters
appear to be mediated by estrogenic metabolites of these
steroids, the influence of ovarian hormones on eating
and body weight regulation in female rats will be
reviewed briefly.
Female rats . The ovarian hormones, 173-estradiol and
progesterone, have marked effects on food intake and body
weight in adult female rats. Withdrawal of these hormones
by ovariectomy results in increased food intake and body
5weight gain. Beginning approximately 30 days after
ovariectomy, food intake returns to the level of intact
rats, and body weight stabilizes at a level 25% above
that of control rats (Gentry and Wade, 1976a; Roy and
Wade, 1977; Stotsenburg, 1913; Tarttelin and Gorski,
1973). The change in weight observed after ovariectomy
is the result of increases in all carcass components.
The most marked increase, however, occurs in carcass fat
content which is 1.6 to 2 times greater (depending on
diet) in ovar iectomized (OVX) rats than it is in intact
female rats (Leshner and Collier, 1973).
The effects of ovariectomy on food intake and body
weight are reversed by 1) systemic injections of
estradiol benzoate (EB; Mook
,
Kenney, Roberts, Nussbaum
and Rodier, 1972; Roy and Wade, 1977; Wade, 1975), or
2) estradiol delivered directly into the ventromedial
hypothalamus (VMH) in OVX rats (Jankowiak and Stern,
1974; Wade and Zucker, 1970). When OVX rats are given
estradiol body fat levels return to those of intact con-
trol rats (Salans, 1971; Gray and Wade, 1981).
In the absence of estrogen, progesterone has no
influence on food intake, body weight or carcass compo-
sition in OVX rats (Galletti and Klopper
,
1964; Hervey
and Hervey, 1966; Ross and Zucker, 1974). However, when
progesterone is given concurrently with estradiol,
6adiposity increases and transient increases in eating and
body weight gain take place relative to rats treated with
estradiol alone (Galletti and Klopper
, 1964; Hervey and
Hervey, 1966; 1967; 1968; Wade, 1975). Similar changes
are seen following progesterone treatment in intact rats
(Hervey and Hervey, 1966; Wade, 1975).
That the effects of the hormonal manipulations re-
ported above are not merely the result of pharmacological
doses of gonadal hormones is indicated by the fact that
food intake, body weight and adiposity vary predictably
with changes in endogenous hormone levels. Food intake
and body weight decrease when circulating estradiol
levels are high (proestrus; Hori, Ide and Miyake, 1968;
ter Haar, 1972 ; Yoshinaga , Hawkins and Stocker, 1969),
and increase when estradiol titers decrease (diestrus;
Brobeck, Wheatland and Strominger, 1947; Rothchild,
1967). In addition, during pregnancy or pseudo-
pregnancy, when progesterone levels are high, food in-
take, body weight and adiposity increase in rats
(Hashimoto, Hendricks, Anderson and Melamey, 1968;
Knopp, Saudek, Arky and O'Sullivan, 1973; Wade and
Zucker
,
1969)
.
Ovarian hormones may act at several sites to
cause changes in food intake and body weight. For years
it had been assumed that gonadal hormones influenced
body weight by acting on specific brain sites con-
taining specific estrogen and progestin receptors to
modulate eating behavior, thus influencing body weight
(Wade, 1976). As discussed by Wade and Gray (1979)
several lines of evidence suggest that this view of
hormone action is incomplete. Implants of EB in the
VMH (but not in other diencephalic sites) do cause re-
ductions in eating and weight gain in female rats
(Jankowiak and Stern, 1974; Wade and Zucker, 1970).
However, since ovariectomy increases and EB treatment
decreases body weight and food intake in rats with
large hypothalamic lesions (Beatty, O'Briant and
Vilberg, 1975; King and Cox, 1973), the hypothalamus
cannot be the only site of action. In addition, changes
in food intake that follow treatment with steroid hor-
mones cannot alone account for the observed changes in
body weight. When progesterone-induced hyperphagia is
prevented in intact rats by restricting food intake to
pretreatment levels, mean body weight still increases
significantly compared to controls (Hervey and Hervey,
1968) . Similarly, OVX rats must be restricted to
approximately 80% of their pre-OVX ad libitum food
intake to prevent the rise in body weight that follows
ovariectomy (Roy and Wade, 1977). Furthermore, when OVX
rats are pair fed with EB-treated OVX rats, they do not
lose weight. Thus, hyperphagia is not necessary for
progesterone- or ovar iectomy- induced weight gain, nor is
hypophagia sufficient to produce decreased weight follow-
ing estrogen treatment in OVX rats.
These studies suggest that ovarian hormones do not
alter body weight by acting solely on the brain to alter
ingestive behaviors. in 1979, Wade and Gray proposed
that ovarian steroids might also act directly on periph-
eral tissues, such as those involved in triglyceride
storage, to influence body weight, food intake and
adiposity. For example, in adipose tissues, they sug-
gested that ovarian hormones might act via high-affinity
steroid-specific cytoplasmic estrogen (Wade and Gray,
1978) and progestin receptors (Gray and Wade, 1979) to
alter activity of the enzyme lipoprotein lipase (LPL)
in female rats. This enzyme plays an essential role in
hydrolysis of plasma triglycerides and their subsequent
storage in adipose tissues (Scow, Hamosh, Blanchette-
Mackie and Evans, 1972). Thus, changes in adipose
tissue LPL activity alter the availability of circulating
triglycerides for storage. Estradiol treatment decreases
adipose tissue LPL activity in OVX rats (Gray and Wade,
1980; Hamosh and Hamosh, 1975) causing decreased fat
storage. Progesterone treatment of intact female rats
or of OVX rats primed with estrogen increases LPL
9activity (Gray and Wade, 1980; 1981; Kim and Kalkoff,
1975) and adiposity (Galletti and Klopper
, 1964; Gray
and Wade
, 1981) .
Ovarian hormones also act on other tissues and
enzyme systems to modulate triglyceride clearance and
synthesis. For example, rat liver contains cytoplasmic
estrogen receptors (Eisenfeld and Aten, 1979), and
estrogens increase hepatic triglyceride synthesis (Kim
and Kalkoff, 1975; 1978) and modulate production of
apoproteins which serve as enzyme cofactors for LPL
and structural elements of plasma lipoproteins (Kim and
Kalkoff, 1978; Patsch, Kim, Wiest and Schonfeld, 1980).
Wade and Gray suggested that changes in food
intake that follow treatment with ovarian steroid might
be a consequence of altered levels of circulating fuels.
For example, the decreased food intake of estradiol-
treated rats might, in part, be due to increased avail-
ability of plasma triglycerides. Changes in body weight
and composition might result from direct metabolic
responses to ovarian hormones. While there is much sup-
port for this latter suggestion, recent data indicate
that hypertriglyceridemia is not necessary for the
estradiol-induced decrease in food intake (Gray and Wade,
1981; Ramirez, 1980; 1981). Thus, other mechanisms may
also be involved in modulating the effects of estrogen
10
on food intake.
Male rats. Castration of adult male rats results in a
decreased rate of weight gain and a reduction in food
intake (Gentry and Wade, 1976a; Kakolewski, Cox and
Valenstein, 1968). The decrease in consummatory be-
havior generally does not appear until approximately one
month post-castration. The attenuation in body weight is
apparent immediately after orchiectomy and is mostly due
to tissue loss. Over time, however, body weight gain
slows such that by three months post-castration, gonad-
ectomized (GDX) males weigh 8% less than intact control
rats (Gentry and Wade, 1976a). The delay between removal
of testicular hormones and changes in androgen-dependent
processes is not unprecedented, a similar lag period is
seen for the reduction of sexual responsiveness after
castration (Bloch and Davidson, 1968; Stone, 1927).
When castrated male rats are given injections of
testosterone propionate (TP) or 5a-dihydrotestosterone
propionate (DHTP) , food intake and body weight increase
(Gentry and Wade, 1976a). Unlike the effects of DHTP,
the effects of testosterone replacement on ingestive
behavior and weight gain are dose-dependent. Low doses
of TP (_< 200 yg/day) increase food intake and body weight
gain (Gentry and Wade, 1976a; Rubinstein and Solomon,
1940) . Higher doses of TP (1-2 mg/day) also produce
increases in these parameters, but within one to two
weeks, body weight and food intake decline (Gentry and
wade, 1976a). The decrease in body weight that follows
prolonged treatment with high concentrations of TP was
termed "the wearing-off effect" (Kochakian, 1975),
since it was believed that the effects of testosterone
simply wore off over time. However, the weight changes
following administration of high doses of this androgen
are primarily due to decreases in adiposity (Hervey and
Hutchinson, 1972; Kochakian, 1975), suggesting that
these decreases may in fact be mediated by estrogenic
products of TP. Further evidence for this hypothesis
is provided in later chapters.
The studies that follow were designed to further
explore the influence of gonadal hormones on food intake,
body weight and carcass composition in male rats. Some
of the sites at which steroid hormones act and mechanisms
by which they act to induce changes in these variables
were investigated.
CHAPTER II
TESTOSTERONE EFFECTS ON FOOD INTAKE AND BODY WEIGHT
IN MALE RATS: ROLE OF ESTROGENIC METABOLITES
Experiment I: Ef fec ts of TP on Food Intake and BodyWeight in GDX Rats Treated witha n ^
Aromatization Inhibitor
It has been postulated that the reduction in weight
gain seen after treatment with high doses (1-2 mg/day) of
TP IS due, in part, to estrogenic metabolites of TP
(Gentry and Wade, 1976a; Hervey and Hutchinson, 1972).
That DHTP, an androgen that cannot be aromatized to
estrogens, does not reduce food intake or body weight
gain even when administered in high doses (20 mg/day;
Gentry and Wade, 1976a) lends credence to this hypothesis.
In addition, concurrent treatment with progesterone
blocks both estradiol-induced decreases in body weight
(Wade, 1976) and the weight-reducing effects of high
doses of TP (Gentry and Wade, 1976a).
Experiment I was designed to test the aromatization
hypothesis. Castrated male rats bearing silastic capsules
containing the aromatase inhibitor, androsta-1 , 4 , 6-
tr iene-3 , 17-dione (ATD) , were given daily injections of
a high dose of TP, and food intake and body weight were
measured. ATD has been shown to prevent estrogen pro-
duction from testosterone in several tissues (Brodie,
12
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Schwarzel and Brodie, 1976; Lieberburg, Wallach and
McEwen, 1977; Schwarzel, Kruggel and Brodie, 1977) and
blocks the effects of aromatizable androgens on male
and female sexual behavior (Christensen and Clemens,
1975; Gladue, Dohanich and Clemens, 1978; Morali,
Larsson and Beyer, 1977), and on sexual differentiation
(Gladue and Clemens, 1980; McEwen, Lieberburg, Chaptal
and Krey, 1977) in rats. if indeed estrogenic metabo-
lites are responsible for some of the changes in body
weight and food intake that follow treatment with high
doses of TP, then ATD should prevent or attenuate these
changes in rats receiving concurrent treatment with high
doses of TP.
Method
.
Animals and housing
. Forty-five male CD-strain
rats (body weight 250-300 g at the time of surgery)
obtained from Charles River Breeding Laboratories were
used in the experiment. The animals were individually
housed in Wahmann LC-75 wire bottom cages and were given
free access to food pellets (Purina laboratory chow) and
tap water. A 12-hour-light : 12-hour-dark cycle (lights
on at 0800 hr) was maintained throughout the experiment.
Steroids and silastic capsules . TP and choles-
terol (C) were purchased from Sigma Chemical Co., and
ATD was purchased from Steraloids Inc. Implants of ATD
14
were each made from 10 cm Silastic tubing (1.47 mm inner
diameter; 1.96 mm outer diameter; medium grade tubing;
Dow Corning) and contained approximately 100 mg of ATD.
The capsules were sealed at both ends with wood plugs
and Silastic adhesive, cleaned with ethanol, and allowed
to cure at room temperature for 24 hours. Prior to
implantation, the capsules were incubated for 28 hours
following the procedure described by Smith, Damassa and
Davidson (1977). Capsules of C (3 cm) were prepared in
similar fashion and implanted in all animals not re-
ceiving ATD.
Procedure
. All animals were castrated under
methoxyf lurane (Metofane; Pi ttman-Moore) anesthesia
through a single scrotal incision. Beginning 4 weeks
after surgery all animals received daily subcutaneous
injections of 0.1 ml sesame oil. Food intake including
spillage (to the nearest 0.1 g) and body weight (to the
nearest g) were measured every third day at approx-
imately 1300 hr throughout the experiment. After 9 days
of oil injections, animals were divided into five
hormone treatment groups matched for body weight and food
intake (Table 1) , and rats were given a subcutaneous
implant of C or ATD under me thoxyf lurane anesthesia.
The groups (n=9 each) were: C + Oil: C implant and
0.1 ml oil/day; ATD + Oil: ATD implant and 0.1 ml
oil/day; C + 1 mg TP: C implant and 1 mg TP/day:
ATD + 1 mg TP: ATD implant and 1 mg TP/day;
C + 0.2 mg TP: C implant and 0.2 mg TP/day. All doses
of TP were dissolved in 0.1 ml of sesame oil.
Data analysis. Data for the three days prior to
hormone treatment were used as baseline. Body weight
data were converted to % baseline for statistical
analysis. Food intake data were converted to calories
(utilizable calories in chow diet = 3.61 kcal/g; Corbit
and Stellar, 1964). Comparisons across groups were
made using one-way analyses of variance. Significant
F values (£<.05) were followed by Newman-Keuls post
hoc tests.
Results .
Body weight (Figure 1, Table 1). Baseline body
weights did not differ significantly across groups. After
15 days of treatment, the three groups receiving TP in-
jections (C + 1 mg TP, ATD + 1 mg TP, C + .2 mg TP) had
gained significantly more weight than their respective
oil control groups, F (4,40) = 14.67, £<. 00001 (£< .01
all post hoc tests)
. Weight gains of the three TP groups
did not differ significantly from one another, and no
significant differences were found between the two oil-
treated groups during the first half of the experiment.
The thirty days of treatment significantly affected body
weight gain, F (4,40) = 11.88, p<. 00001. At the end of
the experimental period the
. 2 mg TP + c and 1 mg TP +
ATD groups had gained significantly more weight than
their respective oil control groups (h<.01, both tests)
In addition, both the
. 2 mg TP + c and 1 mg TP 4- atd
groups gained significantly more weight than the 1 mg
TP + C group (£<.01, p<.05, respectively). No signif-
icant differences were found between the two oil groups
Food intake (Figure 1, Table 1). No significant
differences were found in baseline food intakes across
groups. In contrast to the findings for body weight,
during the first 15 treatment days only the group
receiving
. 2 mg TP + c ate significantly more than its
respective oil control group, F(4,40) = 3.95, p<.01
(£<.01, Newman-Keuls)
. Neither the 1 mg TP + C and
1 mg TP + ATD nor the Oil + c and Oil + ATD groups dif-
fered significantly from each other. During the last
15 days of treatment, all three TP treatment groups ate
significantly more than their respective oil control
groups, F (4,40) = 7.09, p<.0002 (£<.05 or better all
post hoc comparisons)
. The three treatment groups did
not differ significantly from one another during this
period, nor was food intake significantly different for
the Oil + C group compared to the Oil + ATD group.
DAYS
Fig. 1. Effect of TP in GDX rats bearing
Silastic implants containing cholesterol
or androsta-1 , 4 , 6-tr iene-3 , 17-dione on
body weight and food intake.
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TABLE 1
EFFECTS OF TP ON BODY WEIGHT AND FOOD INTAKE
IN ATD- OR CHOLESTEROL-TREATED RATS
352. 3 378 . 8 399. 0 98. 4 90. 4 91. 9
+ 15. 4 + 17. 3 + 17. 4 + 3. 8 + 3. 2 + 2. 7
354. 1 385 . 0 408. 4 98. 4 92. 6 97. 5
± 9- 6 + 12. 2 + 12. 2 + 1. 9 + 2. 8 + 2. 5
352. 4 401. 2 413. 2 99. 0 98. 8 104. 2
± 8. 6 + 10. 6 + 9. 6 + 3. 4 + 2. 4 + 2. 5
351. 6 407. 2 431. 4 99. 9 97. 4 111. 6
+ 10. 9 + 14. 4 + 17. 1 + 3. 6 + 3. 5 + 4. 3
350. 4 413. 3 442. 8 102. 7 105. 9 111. 6
+ 10. 9 + 12. 6 + 14. 2 + 3. 0 + 3. 2 + 3. 8
BODY WEIGHT (q) FOOD INTAKE (kcal/dav^
^^QUP BAh!ELIN5 15---^^—3TJ i.Abi:]LibJi:] l-lb'^''^6-3
0
OIL + C
OIL + ATD
1 mg TP + C
1 mg TP + ATD
.2 mg TP + C
Data are presented as mean + S.E.M.
Experiment II: Effects of TP on Cytoplasmic
Estrogen Binding and LPL Activity in
Epididymal Adipose Tissues of GDX
Rats Treated with an Aromatization
Inhibitor
Earlier findings indicate that long-term treatment
with high doses of TP decreases the amount of carcass
fat in male rats (Hervey and Hutchinson, 1972; Kochakian
and Webster, 1958). It has been shown that estrogens
may act directly on adipose tissues (Wade and Gray, 1978)
,
and that aromatization of androgens occurs in some adipose
tissues (Kley, Deselaers, Peerenboom and Kruskemper, 1980;
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Nimrod and Ryan, 1975; Perel and Killinger, 1979).
Thus, estrogenic products of testosterone might pos-
sibly be acting on adipose tissues to alter carcass
composition. Estradiol may, in part, decrease carcass
fat content by decreasing adipose tissue LPL activity.
Recent studies have demonstrated that male and female
rat adipose tissues contain high-affinity, steroid-
specific cytoplasmic estrogen receptors (Gray and Wade,
1980; Wade and Gray, 1978) and that estrogen treatment
lowers adipose tissue LPL activity in rats of either sex
(Hamosh and Hamosh, 1975; Wilson, Flowers, Carlile and
Udall, 1976) .
In Experiment II the effects of long-term TP
treatment, with or without supplemental ATD, on cyto-
plasmic receptor concentration and LPL activity in
epididymal adipose tissue were examined in GDX male rats.
In addition, retroperitoneal and epididymal adipose tissue
weights were recorded. These two fat pads were chosen
because they have been shown to contain saturable,
steroid-specific cytoplasmic estrogen receptors. If
decreased carcass fat content of males given high doses
of TP is mediated by estrogenic metabolites, then this
hormone treatment should both deplete cytoplasmic
estrogen receptors (estrogen receptors should be trans-
located to cell nuclei) and reduce LPL activity in rat
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adipose tissues. These effects should be blocked or
attenuated in rats receiving ATD.
Method
.
Animals and housing. Rats were those used in
Experiment I.
Procedure. At the completion of the injection
period (Experiment I) all rats were killed by decap-
itation. Epididymal and retroperitoneal adipose tissues
were dissected and weighed. Because epididymal fat pads
have the highest concentration of cytoplasmic estrogen
receptors in male rat adipose tissues (Gray and Wade
,
1980)
,
epididymal fat pads were used for cytoplasmic
estrogen receptor studies (left pad) and LPL assay
(right pad)
.
Cytoplasmic estrogen receptor assay . Left
epididymal fat pads were homogenized in ground glass
tissue grinders (Duall size 23; Kontes) at a concentra-
tion of 400 mg/ml buffer containing 10 mM Tris-HCL,
1.5 mM EDTA, 12 mM monothioglycerol and 10% (v/v)
glycerol, pH 7.4 (TEMG)
. Cytoplasmic estrogen binding
was measured as described by Wade and Gray (1978) with
the exception that TEMG buffer was used in this assay.
Protein concentrations were measured according to the
method of Lowry, Rosebrough, Farr and Randall (1951).
Lipoprotein lipase assay. Right epididymal fat
21
pads were homogenized at a concentration of 250 mg tissue
per ml of medium containing 0.25 M sucrose and 1 mM EDTA,
PH 7.4. Postmitochondrial supernatants were obtained
following centrifugation of the homogenate at 12,000 g
for 15 minutes. Lipoprotein lipase activity was assayed
by the method of Schotz, Garfinkel, Huebotter and Stewart
(1970) .
Data analysis. Data were analyzed using one-way
analyses of variance. Significant F values (p<.05)
were followed by Newman-Keuls post hoc tests.
Results
.
No significant differences were found in
epididymal or retroperitoneal fat pad weights across
groups. However, the ATD + 1 mg TP group had a mean
epididymal fat pad weight that was at least 50% higher
than those of the other groups. In addition, retro-
peritoneal fat pads from the C + 1 mg TP group (mean
fat pad weight + S.E.M. = 3.05 + 0.25 g) had lower
weights than those from the .2 mg TP + C (4.40 + 0.26 g)
and the oil control groups (4.40 + 0.48 and 4.82 +
0.70 g, respectively, for C + Oil and ATD + Oil).
A significant decrease in available cytoplasmic
estrogen receptors was found in the epididymal fat pads
of the C + 1 mg TP treatment group compared to each of
the other groups, F (4,39) = 8.1, p<. 00001 (p<.01 all
post hoc tests; Figure 2) . The other four groups did
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not differ significantly from one another on this
measure. Similarly, LPL activity was significantly
decreased in the C+ 1 mg TP group compared to all other
groups, F (4,36) = 5.57, £<.001 (£<.01 all comparisons),
whereas no other significant changes in enzyme activity
were found between groups (Figure 2)
.
Discussion
The results of Experiment I are in agreement with
earlier observations of a dose-dependent effect of TP
on weight gain in male rats (Gentry and Wade, 1976a;
Kochakian and Endahl, 1959; Kochakian and Webster, 1958),
During the first two weeks of hormone treatment all
groups receiving TP gained more weight than the oil
control groups. After this period weight gain slowed in
the group receiving the high dose of TP + C such that
by the end of the experimental period the low dose TP
+ C group and the 1 mg TP + ATD group had gained signif-
icantly more weight than the high TP group or oil con-
trols. Treatment with ATD alone had no significant
effect on body weight gain. Food intake was also
increased by testosterone treatment. At the end of
treatment all groups receiving TP were eating signif-
icantly more than were the oil control groups. Food
intake of the high dose TP group was lower than that of
the low TP group and the high TP + ATD group, but this
difference was not statistically significant (Table 1).
These observations support the hypothesis that the dose-
dependent effects of TP result from the aro.atiza t ion
of testosterone to estrogens (particularly estradiol)
in rats treated with high doses of TP. indeed, during
the last 15 days of hormone treatment, food intake and
body weight gain of rats receiving the higher doses of
TP concurrently with ATD were quite similar to those of
animals treated with low amounts of TP.
In the earlier phase of the experiment, food in-
take and body weight did not always change in parallel
as one would expect if body weight gain directly re-
flected food intake. Whereas by day 15 all TP treatment
groups had gained significantly more weight than the
oil control groups, food intake during the first 15
experimental days was only elevated in the low dose
TP group. As will be discussed more fully in Chapter IV,
androgens have anabolic effects (Bardin, Bullock, Mills,
Lin and Jacob, 1978; Kochakian, 1975); the increased
weights of the TP groups might be due to the anabolic
actions of the hormone. In addition, at the end of the
experiment, the high dose TP group weighed significantly
less than the other two TP groups, but the food intake
of the high TP group did not differ significantly from
that of the 1 mg TP + ATD group or the . 2 mg TP + C
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group. In light of the fact that androgens do have
anabolic effects it is reasonable to suggest that rats
might be eating for nutrients other than calories (e.g.,
protein). However, since no diet selection was per-
mitted, the animals had to balance multiple metabolic
needs through ingestion of a single diet. Other experi-
ments have demonstrated that for female rats given cer-
tain gonadal hormones, food intakes and body weights need
not change in parallel (Hervey and Hervey, 1968; Roy and
Wade, 1977)
.
In Experiment II, cytoplasmic estrogen receptors
and LPL activity were measured in the epididymal fat
pad, an adipose tissue that has been shown to contain
estrogen-specific, high affinity receptors for estradiol
in male rats (Gray and Wade, 1980). Animals given high
doses of TP had fewer available cytoplasmic receptors
in this depot than did oil-treated control animals or
than rats treated with low doses of TP. Human adipose
tissues contain enzymes necessary for aromatization of
androgens to estrogens (Kley et al., 1980; Nimrod and
Ryan, 1975; Perel and Killinger, 1979). Thus, it is
likely that in rats receiving C + 1 mg TP, some testos-
terone is converted to estradiol which then depletes
available cytoplasmic estrogen receptors, possibly by
causing translocation to cell nuclei. The estrogen
specificity Of the receptor aepXetion is demonstrated by
Its absence in animals treated with 1 tp but given
the aromatase inhibitor, ATD.
LPL activity closely paralleled the cytoplasmic
estrogen receptor data (Figure 2). These results con-
firm and extend a previous report by Wilson and colleagues
(1976) Which Showed that chronic treatment of male rats
with low doses of testosterone (500 ,g/week) had no
effect on adipose tissue LPL activity, whereas estradiol
administration significantly lowered activity.
Although estrogen receptors were depleted and LPL
activity was decreased in rats treated with high doses
of TP, mean epididymal fat pad weight for this group was
not significantly lower than in rats receiving lower
doses of TP. The failure to find a decrease in
epididymal fat pad weight is in agreement with an earlier
report by Krotkiewski (1976) that found the epididymal
pad (but not other fat pads) to be spared from the
anorexic effects of synthetic steroid hormone
(dexamethasone) treatment. In contrast, retroperitoneal
fat pad weights were lower in the high dose TP group
than in all other groups.
A decrease in body weight, a depletion of adipose
tissue cytoplasmic estrogen receptors and a reduction
in adipose tissue LPL activity are changes seen after
treatment with estradiol. All these effects were
Observed in male rats given long-term treatment with
high doses of TP. None of these changes were observed
with low doses of TP, or when high doses of TP were
administered in conjunction with the aromatase in-
hibitor, ATD. Taken together, these data lend strong
support to the hypotheses (Gentry and Wade, 1976a;
Wade and Gray, 1979) that the weight-reducing effects
of high doses of TP are mediated via aromatization to
estrogens, and that estradiol has a direct effect on
adipose tissue metabolism, including LPL activity.
CHAPTER III
ANDROGEN EFFECTS ON FOOD INTAKE: CENTRAL
SITES OF ACTION
Experiment III: Ef fects of Diencephalic Andro n>:^n
Implants on Food Intake in GDX Male Rats
Evidence supporting a direct effect of estrogens
on male rat adipose tissues (Experiments I and III)
does not preclude the possible involvement of other
peripheral and central mechanisms in the androgenic
regulation of food intake and body weight. In 1970,
Wade and Zucker showed that implants of EB into the
VMH in OVX rats resulted in a reduction in food intake
that was similar to that seen after systemic injections
of EB. Implants of this hormone in other diencephalic
sites produced no reliable changes in food intake.
These results have subsequently been replicated in
several laboratories (Beatty, O'Briant and Vilberg,
1974; Jankowiak and Stern, 1974; Roy, Maass and Wade,
1977). Thus, estrogens may act on central as well as
peripheral tissues (Wade and Gray, 1978; 1979) to
affect food intake and body weight regulation.
In the present study, the possible involvement of
central mechanisms in androgen-induced changes in food
intake in GDX male rats were examined. Two anatomical
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sites, the VMH and the preoptic-anter io. hypothalamic
area (POA) were directly stimulated with TP or DHTP.
The VMH and POA have been shown to contain both
androgen and estrogen receptors (Barley, Ginsburg,
Greenstein, Maclusky and Thomas, 1975; Eisenfeld, 1970;
McEwen, 1976) as well as aromatizing enzymes (Naftolin,
Ryan, Davies, Reddy, Flores, Petro, White, Takoaka and
Wolin, 1975). These regions have been implicated in the
mediation of several of the behavioral effects of
gonadal hormones (Davis and Barfield, 1979a; 1979b;
Smith, Damassa and Davidson, 1977; Wade and Zucker,
1970) including eating behavior (Beatty, O'Briant and
Vilberg, 1974; Jankowiak and Stern, 1974; Roy et al.,
1977; Wade and Zucker, 1970).
Method
.
Animals and housing
. Adult male CD-strain rats
(body weight 300-330 grams at the time of surgery)
obtained from Charles River Breeding Laboratories were
used. Rats were individually housed in hanging cages
with free access to food pellets (Purina rodent chow)
and tap water. A 12:12 light-dark cycle (lights on at
0800 hr) was maintained throughout the experiment.
Procedure
. All animals (n = 14) were castrated
via a single incision under me thoxyf lurane anesthesia.
After a 2-week recovery period the animals were
anesthetized with sodium pentobarbital (Nembutal;
40 mg/kg) and stereotaxically implanted with bilateral,
concentric double-walled stainless steel cannulae
(inner 27 ga; outer 22 ga) . The cannulae were aimed
at the VMH (n = 7) or at the POA (n = 7) . The
coordinates for each placement were: VMH: anterior
5.6, lateral 1.0, vertical
-3.2; POA: anterior, 7.6,
lateral 1.0, vertical
-2.0 (Pellegrino and Cushman,
1967).
Beginning 2 weeks after stereotaxic surgery, food
intake was measured daily between 1030 and 1100 hr for
the duration of the experiment. Food spillage was
collected, and 24-hour food intakes were recorded to
the nearest
.1 g. After obtaining stable daily intakes
(less than 10% variation in food intake over at least
3 days)
,
72-hour periods of hormone treatment were
initiated. To deliver the hormone, the inner cannulae
were removed and the tips (190 ym inner diameter) were
filled with undiluted crystalline TP (Sigma Chemical
Co.) or DHTP (Steraloids Inc.) following the procedure
described by Wade and Zucker (1970) . The hormone-filled
cannulae were then reinserted into each animal's implanted
outer cannulae where they remained for 72 hours. Inner
cannulae were removed between 1100 and 1130 hr and were
replaced by empty inner cannulae of identical
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construction. Rats were tested with both hormones in
random order. Each test was separated by at least
7 days of stable intakes. The average daily intake
for the three days preceding each test was used as
a baseline to assess the effects of the hormones.
Histology. At the completion of testing, all
animals were given an overdose of sodium pentobarbital
and perfused intracardially with 0.9% NaCl followed by
10% Formalin. Brains were removed, and frozen coronal
sections were cut at 40 pm, stained with cresyl violet
and examined microscopically to determine cannulae
placements
.
Results
.
An animal showing a change in mean food intake
of 15% or more during the three days of hormone treat-
ment from its prehormone baseline value (mean intake
during the three days prior to hormone implantation) was
considered to have a positive response to the hormone.
When tested with TP, 5 of the 7 animals with implants
in the VMH met this criterion (Figure 3A) . Food intake
of these animals during TP treatment decreased an
average of 28.6% (mean intake + S.E.M. = 71.4 + 3.4% of
baseline)
. Implants of TP in the POA failed to change
food intake by more than 5% in any individual animal
(mean = 103.4 + 2.4%). The two groups differed signif-
icantly in responses to TP stimulation (Fisher test.
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E<0.05, two-tailed). when DHTP was placed in the VMH
or POA, no positive responses were obtained from any
of the animals tested (mean for VMH implants =
101.0% + 2.7%; mean for POA implants = 99.4 + 1.6%).
For the group with VMH implants, the effect of TP treat-
ment was significantly different from that of DHTP
(Wilcoxon matched-pairs, signed ranks test, £<0.05).
Implants in the VMH that resulted in positive
responses to hormonal stimulation were located dorso-
lateral to the ventromedial nuclei. The implants for
the POA group were located in the pr eopt ic-anter ior
hypothalamic area lateral to the supr achiasma t ic nuclei
(Figure 3A)
.
Experiment IV: Effects of VMH Implants of EB
,
TP, or DHTP on Food Intake in GDX Male Rats
In Experiment III, it was shown that bilateral
implants of TP in the VMH reduced food intake in GDX
male rats, whereas similar implants in the POA or VMH
implants of DHTP had no effect on food intake. If TP
implanted in the VMH decreases food intake via estro-
genic metabolites, then EB should produce a similar
decrement in food intake. In the present experiment
rats were given bilateral cannulae implants in the VMH
and were tested for the effects of TP, DHTP and EB on
food intake. In addition, a second group of rats was
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Fig. 3. Location of diencephalic hormone
implants. Positive (squares) and negative (circles)
sites are indicated on coronal sections adapted from
Ktinig and Klippel (1963) ; numbers in the lower right
refer to plates in the atlas. Numbers inside symbols
identify individual rats. In Figure 3A (left panel)
positive sites indicate responses to TP stimulation
(Experiment III) . In Figures 3B (middle panel) and
3C (right panel) positive sites refer to EB or TP
stimulation (Experiment IV) . Animals Number 26 and
32 responded to TP only; Numbers 21, 22, 25, 34, 38
and 40 responded to EB only; Numbers 24, 29 and 30
responded to both EB and TP. Numbers 23 and 36 were
not tested with EB.

35
given unilateral implants in the VMH, and the effects
of the above hormones on food consumption were
examined
.
Method
.
Animals and housing. Twenty adult male CD-strain
rats (weighing 300-330 grams at the time of surgery)
were used. Rats were housed and maintained as were
the animals in Experiment III.
Procedure. Rats were castrated as previously
described. Following the procedures described in
Experiment III, rats were given unilateral (n = 10) or
bilateral (n = 10) implants of concentric cannulae
aimed at the VMH. Rats were tested with TP, DHTP and
EB as described in Experiment III. The histological
procedures used were those described in Experiment III.
Results. Bilateral implants of TP in the VMH reduced
food intake by more than 15% from baseline in 5 of 10
animals (mean = 75.8 + 2.2%). None of the rats in this
group changed its mean intake by more than 7% when
tested with DHTP (mean = 100.5 + 1.2%). Nine of these
10 animals were also tested with EB and 6 responded
with reductions in food intake that were greater than
15% (mean = 76.3 + 3.3%). Three of the 6 EB-responder
s
had shown similar decreases in food intake in response
to TP, the other 3 animals responded to EB but not to TP
(Figure 3B)
.
The effects of TP and EB were significantly
different from the effect of DHTP on food intake (Chi
square test, £<0.01 in both cases).
Of the 9 animals with unilateral VMH implants,
3 lost their implants shortly after the first hormonal
test and were excluded from the experiment. Of the
remaining 6 rats, only 1 responded to TP (20.7% re-
duction)
,
and 3 responded to EB (mean = 76.3 + 1.8%).
Treatment with DHTP did not affect food intake in
5 animals (mean 96.5% + 2.8%). However, 1 animal showed
a 16.2% reduction during DHTP treatment, and this animal
(Number 35, Figure 3C) failed to respond to TP and EB.
Differences between treatments were not statistically
significant (Chi square test, £>0.05).
As in Experiment III, most of the effective
implants were located dorsolateral or lateral to the
ventromedial nuclei (Figure 3B and 3C) .
For all animals in the study (as well as in
Experiment III)
, effective implants had their m.ost pro-
nounced effect during the first 24 hours of hormonal
stimulation. In almost all cases, the animals returned
to pretreatment baselines within three days after the
removal of the hormone. For 3 animals, food intake
stabilized at a lower baseline (10-12% reduction) after
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a positive response to the treatment.
Discussion
Castrated male rats given peripheral injections
of TP in high doses show an initial increase followed
by a permanent reduction in food intake and body-weight
gain compared to rats given lower doses of the hormone
(Experiment I; Gentry and Wade, 1976a). It has been
proposed that hormone- induced changes in LPL activity
may be partly responsible for some of the effects of
high doses of TP on food intake, body weight and
adiposity. The present results suggest that in addi-
tion to its peripheral effects, TP may act directly in
the hypothalamus to influence food intake in male rats.
These observations may reflect a direct effect on
feeding behavior or a change in metabolism that in-
directly affects food intake. In this as well as other
studies (Beatty et al., 1974; Jankowiak and Stern,
1974; Roy et al., 1977; Wade and Zucker, 1970), the
implants that were effective in changing food intake were
located in the VMH. This neural area has long been
implicated in the control of feeding behavior (Grossman,
1975; Panksepp, 1974) as well as in the modulation of
endocrine and autonomic-nervous system functions that
may alter metabolism (Bray, 1974; Bray and Nishizawa,
1978; Gisel and Innes, 1979) and thereby indirectly
affect feeding behavior (Friedman and Strieker, 1976).
AS shown in Chapter I, some of the effects of TP
on adipose tissues seem to be mediated by estrogenic
metabolites of the hormone. A similar mechanism may
also be responsible for the central effects of TP on
food intake. That hypothalamic implants of EB reduce
food intake in male rats (Beatty et al.
, 1974) lends
credence to this view. m addition, in the present
experiments, EB treatment tended to be more effective
than TP in reducing food intake, whereas treatment with
DHTP, a non-aromatizable androgen, failed to have any
effect on this measure. It is interesting to note that
the positive anatomical sites in the present study were
very similar in location to those reported for female
rats (Beatty et al., 1974; Jankowiak and Stern, 1974;
Roy et al., 1977; Wade and Zucker, 1970). Here again,
as in the case of feminine sexual behavior (Davis and
Barfield, 1979), estrogenic stimulation of VMH produces
quite similar responses in male and female rats
(Beatty et al.
, 1974)
.
It cannot be assessed from the present data
whether any of the hormones administered migrated to
sites other than the VMH. However, implants in the
anterior hypothalamus and preoptic area were ineffective
in reducing food intake, suggesting some degree of
anatomical specificity of the hormone effect. Further-
more, the effects were evident within the first 24 hours
of hormone administration. Thus, the hormone is
probably acting on neural tissue near the site of the
implant. it is also unlikely that any of the reported
effects are the result of leakage of the hormone to
the periphery, since systemic administration of TP,
even in high doses, produces an initial increase in
food intake (Experiment I; Gentry and Wade, 1976a).
The rapid reduction in food intake seen after effective
TP implants argues against a peripheral effect.
Finally, unilateral implants of EB in the VMH reduce
food intake in female rats, but have no effect on
cytoplasmic estrogen receptor concentration or LPL
activity in adipose tissues in these animals (Nunez,
Gray and Wade, 1980). These data suggest that estrogenic
stimulation of the VMH (independent of any peripheral
effects of the hormone) may be sufficient to produce
hypophagia, and support the notion that the effects
observed in Experiments III and IV are not the result
of leakage of the hormones to non-neural sites.
CHAPTER IV
EFFECTS OF ANDROGENS ON DIETARY SELF-SELECTION, BODY
WEIGHT AND CARCASS COMPOSITION IN CASTRATED MALE RATS
While it is known that ovarian hormones alter
selection of dietary components by rats (Leshner and
Collier, 1973; Leshner, Siegel and Collier, 1972;
Richter and Barelare, 1938; Wurtman and Baum, 1980),
little is known about the role of androgens in deter-
mining choice of dietary constituents. in the follow-
ing studies, the dietary self-selection patterns of
GDX males receiving one of two doses of either TP or
DHTP were examined. The effects of these hormones on
carcass composition were also investigated. The analysis
of carcass composition was of interest because 1) it was
not known which carcass components were affected during
weight gain that is induced by chronic administration
of low doses of TP, and 2) the effects of a non-
aromatizable androgen (DHTP) on carcass composition had
not been studied.
Experiment V: Testosterone and Protein Intake
As discussed in preceding chapters, several lines
of research suggest that the lowered body weights of males
given high doses of TP are due, at least in part, to
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metabolic effects of estrogenic metabolites of the
hormone (Gentry and Wade, 1976a; Hervey and Hutchinson,
1972; Kochakian, 1950). The mechanism by which tes-
tosterone increases body weight is less clear.
It is known that testosterone, primarily via its
5a-reduced metabolite, DHT, stimulates growth in genital
tissues containing specific cytoplasmic androgen recep-
tors (and the enzyme 5a-reduc tase)
, such as prostate
and epididymis (Liang et al., 1977; Mainwaring, 1977).
Yet, the testosterone-induced gain in body weight is
larger than that which can be accounted for by growth
of reproductive tissues (Kochakian, 1946). m addition
to its androgenic action in accessory sex organs, tes-
tosterone increases nitrogen retention and deposition
of protein in other peripheral tissues (Kochakian, 1975;
Rogozkin, 1979). These anabolic actions have been
demonstrated in tissues containing cytoplasmic androgen
receptors, but which have little or no 5a-reductase
activity (i.e., skeletal muscle and kidney; Bardin et
al., 1978; Krieg and Voigt, 1977; Mainwaring, 1977); sug-
gesting that unmetabolized testosterone (or some testos-
terone metabolite other than DHT) may itself have
anabolic effects.
That testosterone has marked protein anabolic
effects is of interest in light of the finding that
intact male rats consume a larger percentage of their
diets as protein when allowed to self-select dietary
components than do self
-selecting female rats
(Leshner and Collier, 1973). As suggested earlier
(Chapter II)
,
the increase in food intake in testos-
terone-treated, GDX male rats might reflect an increase
in consumption of a particular nutrient such as protein.
However, because rats in that experiment were fed
standard laboratory chow, and thus could only increase
protein intake by increasing ingestion of the entire
diet, this hypothesis could not be tested. An ex-
tensive body of literature has established that rats
do have the capacity to regulate protein consumption
independently from total energy intake under a wide
range of varying physiological and environmental con-
ditions (Anderson, 1979; Booth, 1974; Collier,
Leshner and Squibb, 1969a; 1969b; Leshner, Collier and
Squibb, 1971; Wurtman and Baum, 1980)
.
Experiment V was designed to test the influence
of TP on intake of dietary components. Castrated
adult male rats, each receiving a daily injection of
either a high or low dose of testosterone, or the
injection vehicle alone, were given access to a pair
of isocaloric diets that were equal in fat content,
but that contained differing amounts of protein and
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carbohydrate
.
Method
Animals and housing. sixty adult male CD-strain rats
were purchased from Charles River Breeding Laboratories,
They were housed singly in a room providing 12 hours of
illumination (lights on at 2400 hr). Rats were
gonadectomized under me thoxyf lur ane anesthesia via a
single scrotal incision. Animals were given unlimited
access to tap water throughout the experiment, and food
pellets (Purina laboratory chow) were provided ad
libitum until the introduction of the experimental
diets
.
Four weeks after orchiectomy, rats were divided
into two groups that were matched in terms of body
weight (n = 30) each. One group (mean body weight +
S.E.M. = 313.9 + 3.9 g) was assigned to the diet con-
ditions given below, and the other was assigned to the
conditions of Experiment VI.
Diets
. Both diets contained 4% (by weight) Hegsted
salt mixture (ICN Pharmaceuticals) , 1.5% Vitamin Diet
Fortification Mix (ICN) and 20% vegetable shortening.
The low protein diet (Diet A) contained 5% of the high
quality protein, casein (purified high nitrogen; ICN)
,
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and 69.5% carbohydrate as cornstarch. The high protein
diet (Diet B) included 40% casein and 34.5% cornstarch.
The diets were isocaloric (4.8 kcal/g)
.
Procedure
.
Adaptation to diets. Four weeks after castration,
food pellets were removed from all cages, and two 8.5 cm
high X 7.0 cm diameter glass jars, each containing one
diet of the diet pair, were attached with springs to the
inside of each cage. Animals were allowed 2 weeks to
adapt to the new diets. if an animal showed a strong
preference for one of the diets during this time, the
diet was removed temporarily so that the rat could gain
experience with the other diet of the pair. Prior to
the collection of baseline data, all animals were
eating from both food jars. The positions of the food
jars were varied throughout the adaptation and experi-
mental periods.
Measurement of food intake and body weight
.
After adaptation to the diets, all rats received daily
subcutaneous injections of . 1 ml sesame oil. Begin-
ning 1 day after the start of oil injections, food
intake (to the nearest .1 g) and body weight (to the
nearest g) were measured every third day approximately
2 hours before lights out. After one week of oil
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injections, animals were matched for body weight, total
food intake and protein intake, and divided into three
hormone treatment groups (n = 10 each). Rats subse-
quently received injections of either 2.0 mg TP or
.2 mg TP in
.1 ml sesame oil, or .1 ml of the vehicle
alone
.
Throughout the experiment food spillage was
minimal for most rats. However, after several weeks of
data collection, one subject in the oil group and one
rat in the
. 2 mg TP group consistently spilled portions
of both diets. All data obtained from these animals
were discarded. Even without these animals the three
groups were closely matched for body weight and con-
sumption of the two diets (Table 2) . Analysis of
variance indicated no significant differences on any
of the dependent measures.
Carcass analysis
. At the end of the experiment, all
animals were given an overdose of sodium pentobarbital
and promptly shaved and eviscerated in preparation for
carcass analysis. Carcass composition was determined by
a modification of the method of Leshner, Litwin, and
Squibb (1972)
.
The eviscerated carcasses were baked at
70° - 90°C until no further weight losses were noted
(2-3 weeks)
. Each dried carcass was homogenized in
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TABLE 2
BASELINE BODY WEIGHT AND INTAKE OF DIETARY^^NENTS^^^^^^
GROUP
BODY WEIGHT TOTAL FOOD PROTEIN ^D^^e"""
Oil 370.4 + 9.7 90.8 + 3.9 17.0 + 2.7 39.4 + 2.7
0.2 mg TP 369.3 + 7.9 91.8 + 2.8 17.3 + 1.8 39.7 + 2.0
2.0 mg TP 371.3 + 7.6 90.2 + 2.6 17.6 + 2.0 38.4 + 2.0
a Waring blender and mixed well to insure homogeneity.
Approximately 0.5 g of the homogenate was used for
determination of lipid content. Lipid was extracted
with 2 X 10 ml petroleum ether. Dr ied-delipidated
samples were dissolved in .3 N KOH, and protein content
was determined by the method of Lowry, Rosebrough, Farr
and Randall (1951)
.
Data analysis
. All food intake data were converted to
calories (based on protein = 4 kcal/g; carbohydrate =
4 kcal/g; fat = 9.1 kcal/g). Separate analyses of
variance were performed on total food, protein, carbo-
hydrate and fat intake over the entire 27-day period.
Since earlier experiments have shown that body-weight
gain and food intake of rats receiving a high dose of
TP increase before the attenuating effects of the TP are
observed, post-baseline data were divided into three
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blocks of 9 days each for further analysis. Separate
analyses of variance were then performed on each of the
(above) dependent measures at each 9-day block.
Analyses of variance were followed by individual com-
parisons of means using Newman-Keuls tests (Winer,
1962)
.
Body weight data were expressed as percentage
change from baseline and were subjected to analysis of
variance followed by Newman-Keuls tests.
Results
Total caloric intake. Testosterone propionate in-
creased total caloric intake throughout the 27 days of
treatment, F (2,25) = 15.05, £<.0001 (Figure 4). Over
the entire injection period, the mean caloric intake of
both the high TP (mean + S.E.M. = 89.7 + 1.9 kcal/day)
and low TP (97.2 + 1.0 kcal/day) treatment groups
differed significantly from that of the oil-treated
group (81.4 + 2.7 kcal/day; £<.01, both tests). In
addition, the group receiving .2 mg TP consumed more
calories than did the group receiving 2.0 mg TP
(£<.05)
.
During the first 9 days, total caloric intake rose
in both groups receiving TP, F (2,25) = 3.41, £<.05
(Figure 4). Total food intake during this time was
significantly higher in the low TP group than in the
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oil-treated controls (2<.05). The group receiving 2.0
mg TP did not differ from either the low TP or oil-
treated groups. Food intake was also significantly
increased by TP administration during days 10-18,
F (2,25) = 10.94, 2<.0004, and days 19-27, F (2,25) =
17.30, £<. 00002 (Figure 4). Individual comparisons
indicated that during days 10-18, the high and low TP
groups ate significantly more than the control group
(£<.05, £<.01, respectively); and the .2 mg TP-treated
animals consumed significantly more than did the 2.0 mg
TP group (£<.05). These differences were also present
during days 19-27 (£<.01, all tests).
Protein intake. Protein intake was increased in both
TP-treated groups throughout the 27-day experimental
period, F (2,25) = 11.94, £<.0001 (Figure 4). The
mean protein intake of both the .2 mg TP group
(mean + S.E.M. = 18.2 + 1.0 kcal/day) and the 2.0 mg
TP group (19.2 + .9 kcal/day) differed significantly
from that of the controls (13.0 + .9 kcal/day); while
the two groups receiving TP did not differ significantly
from one another.
That hormone treatment affected protein intake at
all three periods was confirmed by separate analyses
on data from days 1-9, F (2,25) = 5.75, £<.01; days 10-18,
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F (2,25) = 1.1, p<.003; and days 19-27, F (2,25) = 12.32,
£<.0002). Post hoc tests indicated that protein con-
sumption was significantly higher for both groups re-
ceiving TP compared to the oil control group (h<.05 for
low TP group, days 1-9; £<.01 for all other comparisons).
The
.2 mg TP and 2.0 mg TP groups did not differ signif-
icantly during any of the 9-day blocks.
Carbohydrate intake. Carbohydrate intake was increased
by the low dose of TP and was relatively unaffected by
the high TP dose, F (2,25) = 5.86, £<.008 (Figure 4).
The mean number of calories consumed as carbohydrate
during the 27 treatment days was significantly higher
in the
.2 mg TP group (mean + S.E.M. = 42.1 + 1.2
kcal/day) compared to either the 2.0 mg TP group
(36.5 + 1.1 kcal/day) or the oil-treated control group
(37.5 + 1.4 kcal/day; £<.05, both tests). Carbo-
hydrate intake did not differ significantly between
the high TP dose group and the oil-injected group.
Carbohydrate intake was not affected by hormone
treatment during the first 9 days, F (2,25) = .88,
£ = .43. However, the effect of TP was evident by days
10-18, F (2,25) = 4.55, £<.02, and was still present
during the last third of the experiment, F (2,25) = 8.35,
£<.002. The low TP group consumed significantly more
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Fig. 4. Effects of high or low doses of TP or
injection vehicle alone on total food (left panel)
,
protein (upper right) and carbohydrate (lower
right) intake in GDX rats fed Diets A and B. Rats
were allowed to self-select from two isocaloric
diets that varied in amounts of protein and
carbohydrate. Data are presented as means +
S.E.M.
^Significantly different from oil-injected group.
'^Significantly different from group receiving
.2 mg TP.
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calories as carbohydrate than did the high TP group or
the oil controls during days 10-18 (£<.05, both tests)
and during days 19-37 (£<.01, both tests).
Fat intake. Since both the diets in this experiment
were isocaloric and each contained 20% fat, fat intake
varied as a function of total caloric intake and
accounted for 37.9% of the total calories consumed.
Body weight
. Testosterone propionate increased body
weight gain during the first 9 days of treatment,
F (2,25) = 17.59, £<. 00002 (Figure 5). Mean weight
gain of the two TP-treated groups was nearly identical
at day 9 of treatment, and thus did not differ signif-
icantly from one another. However, both groups gained
significantly more weight than did the controls (£<.01,
both TP groups)
.
After the ninth day of treatment, body weight
continued to rise in the group receiving .2 mg TP,
while weight gain began to slow in the 2.0 mg TP
group. An analysis of variance at day 18 indicated a
significant treatment effect, F (2,25) = 17.10,
£<. 00002. Post hoc tests revealed that body weights
were significantly higher in the two TP treatment groups
compared with the oil-treated group (£<.01, both TP
groups), but the .2 mg TP group weighed significantly
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more than the 2.0 mg TP group (e<.05).
At the end of the 27-day treatment period, body
weight gain had slowed greatly in the high TP group
While the low TP group continued to gain rapidly,
F (2,25,
= 15.07, E<. 00005. By day 27, the group re-
viving
.2 ™g TP weighed significantly
.ore than the oil
(E<.01) and 2.0 mg TP group (e<.oi,. The high TP group
was not Significantly different fro. controls. The body
weights ,:.ean
^ s.E.M.) of the oU, low TP and high TP
groups at day 27 were, respectively, 415.7 + 9.8 g,
474.3 + 7.1 g and 438.8 + 11.2 g.
Carcass composition. Carcass analyses are reported in
Experiment VI.
Discussion
The results of Experiment V extend those of
earlier studies v.hich reported a dose-dependent effect
of TP on body weight gain and food intake in castrated
male rats (Experiment I; Gentry and Wade, 1976a;
Kochakian and Endahl, 1959; Kochakian and Webster,
1958). Low doses of TP increased body weight gain and
total food intake more than did higher doses of TP.
It was proposed that TP-treated rats might
increase food intake to acquire a greater quantity of
some specific macronutr lent (e.g., protein). The
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present data suggest that this is not the case for
self-selecting GDX rats given long-term treatment with
.2 mg TP. The increased caloric intake of these animals
was due to enhanced consumption of both carbohydrate and
protein. However, it should be noted that during the
first 9 treatment days, protein intake was significantly
elevated in the low TP group, whereas calories consumed
as carbohydrate did not differ from the vehicle-treated
control animals.
In contrast, injections of 2.0 mg TP had a
striking effect on intake of a single nutrient,
protein. Beginning after the ninth day of treatment,
total caloric intake in the high TP group decreased
significantly compared with the low TP group, yet
consumption was still significantly higher than that
of the controls. At the same time, the number of
calories ingested as carbohydrate were nearly identical
to that of controls. However, protein intake was sig-
nificantly elevated in the high-dose TP group compared
to the controls throughout the experiment. Thus, the
increased food intake in the 2.0 mg TP group observed
during the last 18 days of treatment was due largely to
enhanced ingestion of protein. That calories ingested
as carbohydrate were similar in the high TP and oil
groups suggests that the increased protein intake of
the high TP group was not aue to an atte.pt to avoid
carbohydrate. Thus, high doses of TP increase protein
intake even when given for a sufficient length of ti™e
to cause a decline in body weight gain.
In Experiment V, the low (51) protein diet con-
tained 69.5% carbohydrate, and the high (40%, protein
diet contained 34.5% carbohydrate. Thus, enhanced con-
suinption of protein and decreased ingestion of carbo-
hydrate might both be manifest as an increase in
calories eaten as protein. To rule out the possibility
that TP-treated animals were eating protein to avoid
carbohydrate, a second group of rats was given access
to a pair of diets that had equal percentages of
protein and of fat, but that contained either a high
or low percentage of carbohydrate. As in Experiment V,
rats each received a daily injection of either .2 mg TP,
2.0 mg TP or the injection vehicle alone.
Method
Subjects
.
Subjects were thirty CD-strain rats. Animals
were housed and fed as in Experiment V.
Diets. Each diet contained 4% (by weight) Hegsted Salt
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Mixture, 1.5% vitamin Diet Fortification Mix, 20% vege-
table shortening, and 25% casein. Diet C contained
49.5% cornstarch as carbohydrate (caloric density of
the diet =4.8 kcal/g)
.
The carbohydrate content of
the second diet, Diet D, was diluted to 25% by the
addition of 24.5% nonnutritive cellulose (hydrolyzed
Alphacel, ICN Pharmaceuticals; total caloric content =
3.82 kcal/g)
.
Procedure
.
Experiment VI was run simultaneously with
Experiment V. The procedure was identical to that of
Experiment V. At the beginning of the diet adaptation
period, the mean body weight + S.E.M. of this group
was 312.9 + 3.9 g.
Prior to the completion of the experiment, food
spillage was detected under the cages of two rats in
the
.2 mg TP group, and all data for these rats were
discarded. Even without these two animals the three
groups were closely matched for body weight and con-
sumption of the two diets (Table 3)
.
Carcass composition and data were analyzed as in
Experiment V.
Results
Total caloric intake . Testosterone propionate increased
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TABLE 3
BASELINE BODY. WEIGHT AND INTAKE DATA FOR RATSFED DIETS C AND D
(Mean + S.E.M.
)
GROUP ^''f ''^^^^ ^^0° PROTEIN HYDRATE
Oil 359.8 ± 4.9 82.7 + 3.8 17.8 + 2.4 33.6 ± 5.1
0.2 mg TP 364.0 +12.6 83.4 + 4.4 17.8 + 2.6 33.2 + 6.1
2.0 mg TP 359.7 + 9.8 85.8 + 4.4 18.3 + 2.9 33.3 + 5.2
total caloric intake, F (2,25) = 5.40, £<.01 (Table 4).
Over the 27-day injection period, mean caloric intake
was significantly higher in each of the groups receiving
TP compared to the oil-treated control animals (p<.05,
both groups. Table 4).
The hyperphagia-inducing effect of TP was evident
in both TP groups by the ninth day of treatment (both
TP groups ate approximately 8% more than controls) , al-
though the groups did not differ significantly in the
first 9-day block, F (2,25) = 1.83, £ = .18. Mean daily
intakes for the .2 mg TP and 2.0 mg TP groups were 20%
and 11% greater, respectively, than controls during days
10-18, F (2,25) = 4.85, £<.017. However, during this
period, only the group receiving .2 mg TP differed sig-
nificantly from the oil-treated controls (£<.05). Mean
caloric intake during days 19-27 was increased by 25%
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in the low TP group and by 22% in the high TP group com-
pared with controls, F (2,25) = 7.86, p<.002. The
caloric intake of each TP group during this last 9-day
block was significantly higher than that of controls
(£<.01, both groups).
TABLE 4
EFFECTS OF LONG-TERI-l TP TREATMENT ON K CALORIES OFDAILY FOOD, PROTEIN, AND CARBOHYDRATE INTAKE IN
RATS FED DIETS C AND D
(Mean + S.E.M.
)
TREATMENT N TOTAL FOOD PROTEIN CARBOHYDRATE
Oil Vehicle 10 76.4 + 2.2 16.6 + .4 29.5 + 1.3
0.2 mg TP 8 89. 3 + 3.4^19.6 + .8^ 34.6 + 1.3^
2.0 mg TP 10 87.1 + 3.4^18.9 + .7^ 33.7 + 1.4^
^Significantly different from oil-injected group.
Protein intake
. The mean number of calories consumed
as protein were also increased by long-term TP treat-
ment, F (2,25) = 5.78, £<.009 (Table 4). Overall,
mean protein intake was significantly increased by TP
whether given in .2 mg (2<.01) or 2.0 mg (£<.05) doses
(Table 4)
.
During the first 9 days of treatment, mean daily
protein intakes for the lov; TP and high TP groups were.
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respectively, 8% and 7. higher than that for controls
(groups did not differ significantly during this time,
F (2,25) = 1.47, p = .25). Again, an augmentation of
the hormone effect was seen over time such that mean
daily protein consumption during days IQ-ls was in-
creased about 21% in the low TP group and 12% in the
high TP group, relative to controls, F (2,25) = 6.05,
£<.007. The protein intake of the low TP group was
significantly different from that of controls (2<.01)
during this period, while that of the high TP group just
fell short of significance (q .95(2,25) = 18.56; dif-
ference between mean daily intake for the high TP
group and oil controls = 18.27). During the last 9 days
of hormone treatment, the .2 mg TP-treated rats were
eating 24% more protein calories and the 2.0 mg TP
group 23% more calories as protein than the oil-treated
rats, F (2,25) = 8.30, £<.002. The mean daily protein
intake of each of the two TP-treated groups during the
last 9 treatment days, differed significantly from that
of the oil-treated controls (2<.01, both groups).
Carbohydrate intake
. Overall, carbohydrate intake was
increased by TP treatment, F (2,25) = 4.36, £<.024
(Table 4)
.
Intake over the 27 day experimental period
was significantly elevated in both TP-treated groups
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compared to the oil-treated group (2<.05, both groups;
Table 4) .
Again, TP enhanced carbohydrate consumption at all
three 9-day blocks. Compared to controls, mean carbo-
hydrate intake during days 1-9 was increased by 2% and
12%, respectively, in the low TP group and high TP
group, although groups did not differ significantly
in this first 9-day block, F (2,25) = 2.05, p = .15.
During days 10-18, carbohydrate intake was 18% and
10% higher, respectively, for the low TP- and high TP-
treated groups compared with controls. As in the first
block, the groups did not differ significantly from one
another during this time period, F (2,25) = 3.16,
2 = .06. Mean carbohydrate intake during days 19-27,
was 26% and 22% higher, respectively, in the low and
high TP-treatment groups compared with the vehicle-
injected group, F (2,25) = 6.29, £<.006. The carbo-
hydrate intake of the two TP-treatment groups differed
significantly from that of the control group (£<.01,
both groups)
,
during this last 9-day injection period.
Fat intake
. Since food intake was increased by TP
treatment, fat intake was also increased. The intake
of fat varied as a function of calories eaten as
protein. Thus, analyses are significant as for protein
intake (e.g., groups differed significantly over the
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27-daY period, F (2,25) = 5.78, £<.009.
Body weiqh t. During the first nine days of treatment,
testosterone increased body weight gain to levels signif-
icantly greater than controls, F (2,25) = 40.29, £<.0001,
in both the high (£<.01) and low (£<.01) dose groups
(Figure 6). At the end of the injection period, mean
body weight gain differed among the groups, F (2,25) =
28.8, p<. 00001. Weight gain was greatest in the .2 mg
TP group, and it was significantly greater than that of
the oil-treated group (£<.01) and the group receiving
the high dose of TP (£<.01). Unlike the animals in
Experiment V, the high TP-dose group gained signif-
icantly more than controls (2<.01) during 27 days of
hormone treatment. At the end of the experiment, the
mean body weights (+ S.E.M.) of the oil, low TP and high
TP groups were, respectively, 402.0 + 6.3 g, 457.4 +
19.7 g, and 430.0 + 13.0 g.
Carcass composition
. Individual t-tests indicated that
diet condition (Diets A,B versus Diets C,D) had no
effect on carcass composition within each hormone treat-
ment group. For further statistical analyses, animals
receiving the same hormone treatment in Experiment V and
Experiment VI were combined.
The high dose of TP significantly increased the
percentage of water in the carcass, F (2,52) = 5.16,
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p<.01), compared to both the low dose (£<.05) and the
oil treatment (£<.05; Figure 7). The percentage of
carcass lipid was decreased by long-term administration
of 2.0 mg TP, F (2,52) = 4.15, p<.02. Carcass lipid
was significantly lower in this group compared with
the
.2 mg TP and oil groups (p<.05, both tests). The
animals receiving
. 2 mg TP did not differ significantly
from controls (Figure 7). The percentage of the carcass
that was protein was not significantly affected by
hormone treatment, F (2,52) = 1.53, p = .23.
Discussion
When TP-treated rats were given an opportunity to
select fewer calories as carbohydrate, carbohydrate in-
take did not decline; instead both doses of TP increased
carbohydrate intake relative to controls. Thus, these
data lend additional support to the contention that the
increased protein intake of males given long-term
treatment with high doses of TP (Experiment V, Figure 4)
is not due to an attempt to avoid carbohydrate.
The increased body weight of the rats given the
low dose of TP is due to increases in all carcass com-
ponents. Testosterone has marked protein anabolic
actions on several peripheral tissues, especially
skeletal muscle. Following testosterone administration.
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Fig. 7. Carcass composition of GDX male rats given long-
term treatment with high or low doses of TP or the
injection vehicle alone. Data are presented as
means + S.E.M.
Significantly different from oil-injected group.
^Significantly different from group receiving .2 mg TP.
protein intake rises in GDX
.ale rats; perhaps as a way
Of ensuring that adequate amounts of a.ino acids will
be available for increased protein synthesis. The
anabolic effects of TP can also be seen in the car-
casses of TP-treated rats. The mean percentage of
protein in the carcasses of these males is not sig-
nificantly higher than the percentage of protein found
in the carcasses of vehicle- treated males, but the
absolute amount of protein in the carcasses of TP-
treated rats was significantly higher than in the oil-
injected animals, F (2,25) = 5.43, £ = .007. The mean
number of grams of protein in the carcasses of rats
treated with either the low TP dose (59.5 + 2.5) or the
high TP dose (55.9 + 2.8) was significantly greater
(£<.01, £<.05, respectively) than that of the control
rats (47.9 + 2.0).
Finally, whether rats were allowed to self-select
from diets containing 5% or 45% protein, or from 25%
protein, diets had no influence on carcass composition.
This finding is in agreement with data from other
studies in which rats were allowed to self-select
dietary constituents (Leshner, 1972; Leshner, Siegel
and Collier, 1972). The protein anabolic activity of
TP (as estimated by nitrogen retention) cannot be
altered by increasing the protein content of the diets
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(diets ranged from 18-43% protein; Kochakian and van der
Mark, 1952). Apparently once adequate amounts of dietary
nutrients are supplied, the proportions of the various
carcass components remain unaltered.
Experiment Vllr ni
h
ydrotes tos terone and Prot ein
Intake ~ " •
Many androgenic responses in the accessory sex
organs of male rats are mediated by the intracellular
formation of DHT from testosterone, and its subsequent
binding to specific receptors (Liang et al., 1977).
Numerous studies have documented the growth-promoting
effects of DHT in prostate and other genital tissues
(Mainwaring, 1977). However, DHT has little anabolic
action, and skeletal muscle lacks 5a-reduc tase , the
enzyme necessary for formation of DHT from testosterone
(Krieg and Voigt, 1977). Furthermore, any DHT formed
in muscle is rapidly metabolized to androstanediols
(Bardin and Catterall, 1981).
Like TP, DHTP also stimulates food intake and body
weight gain in GDX male rats (Gentry and Wade, 1976a),
but the magnitude of these DHTP effects are much
smaller than those observed after TP administration.
In addition, high doses of DHTP do not reduce weight
gain (unlike TP)
,
likely because DHTP cannot be aroma-
tized to estrogens (Gentry and Wade, 1976a) . Thus,
because of its growth promoting actions i„ so^e periph-
eral tissues and its influence on body weight, it was
Of interest to investigate the effects of DHTP on in-
take Of dietary components and body composition in GDX
male rats
Method
Animals and hous ing. Subjects were 30 CD male rats.
Animals were housed, fed and castrated as in Experiment
V, except that lights were on from 2400 hr to 1200 hr
.
Diets. The experimental diets were diets A and B
used in Experiment V.
Procedure
.
Adaptation to diets. Four weeks after castra-
tion, rats were placed on the experimental diets (as
in Experiment V) for a period of 1 week. Adaptation
was as in Experiment V.
Measuremen t of food intake and body weight .
After adaptation to the diets, all rats were given
daily subcutaneous injections of .1 ml sesame oil.
Food intake and body weight were measured twice weekly.
After 7 days of oil injections, rats were assigned to
one of three treatment groups (n = 10 each group)
matched for body weight and total food, protein and
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carbohydrate intake (Table 5,. Rats received daily
injections of either 2.0 ™g dhtp,
.2 r„g dhtp, or the
sesame oil vehiclp aiin ie. AH mnections were given in .1 ml
sesame oil.
TABLE 5
BODY WEIGHT AND DIETARY INTAKE FOR RATS FFDDIETS A AND B PRIOR TO DHTP OR OIL
INJECTION
(Mean + S.E.M.)
(grams) (kcal/day) (kcal/day) (kcal/day)
OIL 355. 6 + 10.9 91.9 + 3. 9 23.2 + 1. 9 33.8 + 1.1
0.2 mg DHTP 354.6 + 11.6 89.7 + 5.2 21. 2 + 2.0 34.5 + 1.9
2.0 mg DHTP 355. 2 + 8.8 93.0 + 3.0 22.0 + 1.6 35.7 + 2.0
Data analysis
.
Data were analyzed by one-way analyses
of variance, followed by Newman-Keuls post hoc tests
where appropriate.
Carcass analysis. Carcass composition was determined
as in Experiment V except for the following modifica-
tions: Carcasses were baked for 3 days, ground in a
Hamilton Beach food processor (#707) , and returned to
the oven and baked as in Experiment V. This modifica-
tion shortened total baking time by about 1 week.
Lipid was extracted with 3 x 10 ml petroleum ether.
Results
Total food intake
. Hormone treatment significantly
increased total caloric intake, F (2,27) = 6.23,
E<.006. Both groups of DHTP- treated animals consumed
significantly more food over the 5-week injection period
than did controls (2<.01, both groups. Figure 8). The
two DHTP-treatment groups did not differ on this
measure
.
Protein intake. Protein consumption was also increased
by DHTP, F (2,27) = 5.12, £<.01. The two hormone-
treated groups did not differ from one another, but
both the
.2 mg DHTP and 2.0 mg DHTP groups ate more
calories as protein than did the oil controls
(£<.05, both groups; Figure 8).
Carbohydrate intake
. Carbohydrate intake was not sig-
nificantly affected by DHTP, F (2,27) = 2.6, £ = .09
(Figure 8)
.
Fat intake
. Calories consumed as fat accounted for
37.9% of the total calories eaten, and thus were sig-
nificantly higher for the two DHTP groups.
Body weight
.
Body weight gain was significantly
Fig. 8. Effects of DHTP or injection vehicle
on total food (left panel)
, protein (upper
right) and carbohydrate (lower right) intake
in self-selecting GDX rats. Rats were given
access to two isocaloric diets (Diets A and
B) that differed only in protein and carbo-
hydrate content. Values are means + S.E.M.
^Significantly different from oil-injected
group.
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increased by DHTP treatment, F (2,27) = 11.42,
£<.0003. The groups receiving DHTP injections had
gained significantly more weight at the end of the
5-week treatment than did the vehicle-injected group
(£<.01, both groups), but total weight gain was not
significantly different between the two DHTP groups
(Figure 9). At the end of the injection period, mean
body weights (j-S.E.M.) for the oil, low DHTP and high
DHTP groups were, respectively, 412.4 + 13. 4 g,
448.0 + 17.3 g and 435.3 + 12.3 g.
Carcass composition. There were no significant dif-
ferences in the percentages of carcass water, F (2,27)
= .28, £ = .76; lipid, F (2,27) = .03, £ = .97; or
protein, F (2,27) = .58, £ = .57, among the three
groups (Figure 10)
.
Discussion
The results of this experiment are in agreement
with the report by Gentry and Wade (1976a) that DHTP
increases body weight gain and food intake in GDX male
rats. Rats given either a high or low dose of DHTP
increase intake of all dietary components, but only
protein consumption is significantly greater in these
animals compared with the oil-treated control group.
Analysis of carcass composition reveals that the
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Fig. 10. Carcass composition of GDX rats given long-termDHTP or oil treatment. Data are presented as means +
S . E.M. —
DHTP-induced weight gain is not restricted to one body
component; the percentages of carcass water, protein,
and lipid do not differ from those of controls. Al-
though protein intake is increased by DHTP, the absolute
amount of carcass protein is not affected by DHTP. That
is, even though DHTP-treated rats weigh more than con-
trols, there are no significant differences in the
mean number of grams of protein in the carcasses of
rats receiving either dose of DHTP compared to the oil-
treated controls, F (2,27^ = 9^: ^ _ ,
, £ - .z^, 2 _ .78 (mean amounts
of protein (g) + s.E.M. in carcasses of the oil, low
DHTP and high DHTP groups are, respectively, 54.2 +
1.8, 56.2 + 2.9 and 53.9 + 2.6)
.
General Discussion
The results of these experiments show that both
TP and DHTP stimulate food intake, protein intake and
body weight gain in GDX male rats. However, several
differences can be discerned in the actions of the two
androgens on these measures, and a comparison of these
actions may be instructive.
First, TP is more effective than DHTP in
stimulating caloric intake and weight gain. After
27 days of injections, the .2 mg TP group had gained
16.5% more weight than did its oil-control group,
Whereas after 28 treatment days the
.2 OHTP group
had gained only 9.2% .ore than its appropriate control
group. Treatment with TP, but not DHTP also increased
carcass protein content. Similarly, during the 27 days
of treatment, the
. 2 mg TP group consumed an average
of 15.8 kcal/day more than did the oil group, but the
.2 mg DHTP group ate only 10.3 kcal/day more than the
controls. These results confirm and extend the work
of Gentry and Wade (1976a) and indicate that the
actions of testosterone on eating and body weight are
probably not mediated by the metabolite, 5a-dihydro-
testosterone. This conclusion is consistent with the
findings that muscle and kidney, where testosterone has
substantial anabolic effects, have little or no 5a-
reductase activity (Bardin et al., 1978; Krieg and
Voigt, 1977; Mainwaring, 1977).
Second, treatment with TP increased both protein
intake and carcass protein content, whereas DHTP in-
creased protein intake without affecting carcass
protein content. These findings indicate that, at
least to some extent, the increased protein intake of
androgen-treated rats is independent of peripheral
anabolic actions of the hormones. However, the fact
that TP was more effective than DHTP in stimulating
protein intake raises the possibility that these
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peripheral anabolic actions could contribute to TP-
induced protein consumption.
Third, the two DHTP doses were equally effective
in altering eating and body weight, but the two TP
doses were not. Rats treated with the high dose of
TP weighed and ate less than those treated with the
low dose, confirming earlier findings. These relative
decreases in food intake and body weight are due to
reductions in carbohydrate intake and body fat con-
tent, respectively. These two findings are fully
consistent with the hypothesis that intake- and weight-
depressing effects of high TP doses are mediated by
aromatized metabolites (i.e., estrogens). Treatment
of OVX female rats with estradiol reduces body fat
content (Gray and Wade, 1981), just as the high TP
dose did in GDX males. Furthermore, Wurtman and Baum
(1980) have recently shown that estradiol treatment de-
creases carbohydrate, but not protein, intake in rats
given a protein-carbohydrate choice similar to that in
Experiments V and VII. Taken together with the earlier
finding that the intake- and weight-reducing effects
of high doses of TP are prevented by concurrent admin-
istration of an aromatase inhibitor (Experiment I) , the
present results provide strong support for the
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contention that aromatization plays a significant role
in the actions of testosterone on eating and body
weight.
CHAPTER V
COPULATION-INDUCED CHANGES IN BODY WEIGHT
Experiments I through VII were designed to in-
vestigate the effects of androgens on weight-related
parameters in castrated male rats. m the majority
of these studies rats were given one of two concen-
trations of an androgen and, for the aromatizable
androgen, testosterone, the influence of the hormone
on several variables was found to be differentiated
on the basis of dose. This raises the question of
whether any of the dose-dependent (particularly high-
dose) effects of testosterone observed in the preceding
experiments were the result of pharmacological manip-
ulations of the testicular steroid, or whether similar
changes are observed in intact male rats.
Experiment VIII ; Dietary Self
-Selection
, BodyWeight and LPL Activity in Copulating Male Rats
There is evidence that intact male rats do experi-
ence changes in gonadal hormone levels under certain
conditions. For example, testosterone levels rise after
copulatory activity (Kamel, Mock, Wright and Frankel,
1975) or when male rats are exposed to stimuli asso-
ciated with sexual encounters (Graham and Desjardins,
1980) . When adult male rats are housed with intact
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female rats or given repeated mating tests, body weight
gain and carcass fat content decrease (Drori and Folman,
1964; Folman and Drori, 1969; Weizenbaum, 1978; 1981).
Similar changes in body weight (Experiments I, v and VI;
Gentry and Wade, 1976a) and adiposity (Hervey and
Hutchinson, 1972; Kochakian, 1975; Kochakian and
Webster, 1958) are observed in adult males given high
doses of testosterone. This suggests that the changes
in body weight and carcass composition seen in sexually
active male rats may be the result of the copulation-
induced increase in circulating testosterone. In addi-
tion, a small reduction in caloric intake has been
observed in some sexually active male rats fed standard
laboratory chow (Weizenbaum, 1981) , and food intake is
lower in GDX rats given high doses of TP than it is in
similar rats receiving lower doses of TP (Experiment I,
Gentry and Wade, 1976a).
The purpose of Experiment VIII was to investigate
the effects of copulation on behavioral and physiological
end-points that are sensitive to testosterone. Sexually
active and sexually inactive male rats were given access
to a pair of isocaloric diets that were equal in fat,
but contained differing amounts of protein and carbo-
hydrate. (The diets in this experiment were the same
as those used to establish the effects of TP
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(Experiment V) and DHTP (Experiment VII) on intake of
dietary components., Body weight as measured through-
out the experiment, and at the completion o£ testing,
adipose tissue LPL activity and seminal vesicle weights
were measured. Seminal vesicle weight has been shown
to be increased in mated male rats compared to unmated
control rats, and this increase is likely due to
elevated testosterone levels (Folman and Drori, 1969).
Method
Animals and housing. Thirty adult CD-strain rats
(Charles River Breeding Laboratories), weighing
350-450 g at the beginning of the experiment, were
housed individually under a 12:12 hour light-dark cycle
(lights off at 1200 hr)
. Purina rodent chow pellets
were available until the introduction of the experi-
mental diets; tap water was available throughout the
experiment.
Stimulus animals for all mating tests were OVX
females treated with EB and progesterone to induce
estrous behavior. Males used in the experiment were
those showing male copulatory behavior in at least one
of two pretests conducted 2-3 weeks before the intro-
duction of the experimental diets.
Diets. Diets were the low protein (Diet A) and h.gh
protein (Diet B) diets used in Experiments v and VII.
Rats were given two weeks to adapt to the experimental
diets prior to data collection. At the end of the two-
week adaptation period, all animals were eating from
both food jars. The position of each jar was varied
throughout the adaptation and experimental periods.
P£Ocedure. After adaptation to the diets, food intake
and body weight were measured twice weekly between
0900 and 1000 hr
.
After one week of baseline data
collection, rats were assigned to one of three groups
(n = 10 each) matched for body weight, total caloric
intake and consumption of the two diets. The treatment
groups are described below.
Copulators (C)
.
These animals were given access
to receptive females two (Weeks 1-4) or three times
(Weeks 5 and 6) per week. During these sex-behavior
trials, each male was placed in a circular test arena
(60 x 60 x 25 cm high) with a wood chip covered floor
for 5 minutes of adaptation. Following this adaptation
period, 2 or 3 receptive females were placed in the
arena and remained there until the male ejaculated.
Sex behavior trials were conducted during the first
4 hours of the dark phase of the illumination cycle,
under dim red light. All males ejaculated on all
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trials. The latencies to ejaculation decreased over
the experimental period (15-45 minutes for Week 1,
3-20 minutes for Week 6)
.
Arena Controls (AC). These animals were individ-
ually placed in an empty test arena containing clean
wood Chips on the floor, and they remained in the arena
for the duration of the sex-behavior trials of their
counterparts from group C.
Home Cage Controls (HC)
. No manipulations were
performed on this group. The animals were handled only
to obtain body weights.
Several weeks into the experiment one animal in
the AC group developed a habit of digging through his
food and tossing it out of his cage. All data for
this rat were discarded as were data from one rat
in the HC group who one week later, also began spilling
his food. Since the two rats had very similar body
weights at the beginning of the experiment, data were
also discarded from one animal in the C group whose
baseline body weight was closely matched to the initial
body weights of these two animals. The recalculated
baseline data for the three experimental groups (n = 9
each) are given in Table 6.
Tissue preparation and LPL assay . All animals were
killed by decapitation between 0900 and 1000 hr , 24 hours
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TABLE 6
BASELINE BODY WEIGHT AND INTAKE OP DIETARY COMPONENTSIN SELF-SELECTING INTACT MALE
j^^^^^^^^
(Mean + S.E.M.)
GROUP
BODY WEIGHT TOTAL FOOD PROTEIN "^DRA^f
"
(grams) (kcal/day) (kcal/day) (kcal/day)
COPULATOR 417.8+10.3 99.7+3.1 21.5+2.140.4+2.7
ARENA 415.7+11.4 98.3+3.1 20.3+2.140.9+1.7
HOME CAGE 414.0 + 12.1 99.7 + 4.6 24.7 + 1.5 37.2 + 3.5
after the last sex-behavior trial. Epididymal adipose
tissues were rapidly dissected and assayed for LPL
activity as described in Experiment II. Seminal
vesicles were dissected, cleaned and weighed wet. Dry
weights of the seminal vesicles were obtained after
the tissues had been dried in an oven at 35°C for
24 hours.
Data analysis. All food intake data were converted
to calories. Separate analyses were performed on
total caloric, protein and carbohydrate intake, as well
as on body weight gain (% baseline) over the 6-week
experimental period. Comparisons across groups were
made using one-way analyses of variance. Significant
F values (p<.05) were followed by Newman-Keuls post
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hoc tests.
Results
Baseline body weights did not differ significantly
across groups, F (2,24) = .03, £>.90. However, by the
end of the six-week experimental period the groups
differed significantly on mean body weight gain,
F (2,24) = 14.5, £<.01. Individual comparisons of
group means showed that the C group had gained sig-
nificantly less weight than had the two control groups
(£<.01, both tests; Figure 11, Table 7). Weight gains
of the AC and HC groups were not significantly different.
TABLE 7
EFFECTS OF COPULATION ON BODY WEIGHT AND
FOOD, PROTEIN AND CARBOHYDRATE INTAKE
(Mean + S.E.M.
)
CARBOHY-
BODY WEIGHT TOTAL FOOD PROTEIN DRATE
GROUP (grams) (kcal/day) ( kcal/day) (kcal/day)
COPULATOR 471.8 + 14. 4 89.1 + 3. 1 21.3 + 1.1 34.3 + 2.0
ARENA 499.1 + 14. 0 91.0 + 2. 9 21.0 + 1.6 35.6 + 1.1
HOME CAGE 505.4 + 15. 2 97.5 + 3. 0 25.4 + 1.5 34.6 + 1.1
Analyses of variance indicated no significant dif-
ferences on any of the baseline food intake measures
(Table 6) . Table 7 shows food intake data averaged over
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Fig. 11. Effect of copulation on body weight
gain. Male rats were either allowed to
copulate to ejaculation two (Weeks 1-4) or
three (Weeks 5 and 6) times per week
(Copulator)
,
given access to an empty
testing arena (Arena) or left undisturbed
in their cages (Home Cage) . Rats had access
to Diets A and B.
the experimental period for the three groups. The groups
did not differ significantly on total caloric intake,
F (2,24) = 2.12, 2>-14; protein intake, F(2,24) = 3.11,
£>.06; or carbohydrate intake, F (2,24) =
.23, £>.70.
It should be noted that although the three treatment
groups did not differ significantly on amount of protein
consumed, the £ value was close to statistical signif-
icance. Thus, to ensure that protein intake was not
significantly elevated in the HC group, data were con-
verted to percent baseline for further analysis.
Again, no significant differences were found across
groups, F (2,24) = .03, £>.90 (mean intakes of protein
(% baseline) + S.E.M. for C, AC and HC groups were,
respectively, 104.2 + 6.6, 106.4 + 5.4 and 106.7 +
10.7. Similarly, no significant differences were found
across groups for percent change from baseline intake
on the two other intake measures.
Individual t-tests indicated that the AC and HC
groups did not differ significantly in terms of either
wet or dry seminal vesicle weights relative to total
body weights, so the two groups were combined on each
of these measures for further statistical analyses.
Animals in group C had significantly heavier mean
seminal vesicle wet weights relative to total body
weight, t = 2.14, p.<.05, and heavier dry vesicle
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weights relative to total body weight, t = 2.30, ^<,02
than the other groups combined (Table 8).
Epididymal adipose tissue LPL activity was not
changed as a result of copulation, F (2,24) =
.06,
£> . 90
.
TABLE
EFFECTS OF COPULATION ON ADIPOSE TISSUE LPL ACTIVITYAND SEMINAL VESICLE WEIGHT
(Mean + S .E.M.
)
SEMINAL VESICLE WEIGHT
CROnP TOT .r^rr,... . WET WEIGHT (maj_ DRYJVEIGHT (ir.q)G U LPL ACTIVITY* /BODY WEIGHT (gj /BODY WEIGHT
(g)
COPULATOR
.095 + .02 2.4 + .15
.74 +
.05
^^^^^
-102 + .02 2.0 t .11 .62 ± .03
HOME CAGE
.097 + .01 2.1 + .13
.64 + .05
LPL activity is expressed as y mole free fatty acid
released per hour per mg protein.
Discuss ion
Sexual activity produced a marked reduction in body
weight gain, thus confirming earlier observations (Drori
and Folman, 1964; Weizenbaum, 1978; 1981). Previous
research has shown that this effect on body weight is
specific to copulation; access to non-receptive females,
voluntary exercise, or exposure to a novel cage fail to
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mimic the effects of copulation (Weizenbaum, 1981). m
the present experiment, experience with the testing
arena was clearly ineffective in reducing body weight.
However, it cannot be determined from the available
data whether the reduction in body weight results
from actual copulation or from exposure to receptive
females. There is evidence that neuroendocrine
changes in male rats can be induced by previously
neutral stimuli that become associated with access to
receptive females (Graham and Desjardins, 1980).
The decreased rates of body weight gain seen in
copulating animals are similar to the body weight
changes of castrated rats treated with high doses of
TP (Experiments I, V and VI; Gentry and Wade, 1976a).
Furthermore, seminal vesicle weights were elevated in
rats allowed to copulate, suggesting that endogenous
testosterone levels were increased in these animals
compared to unmated control rats.
When high doses of TP are given to GDX male rats,
the subsequent reduction in body weight gain is gener-
ally accompanied by a reduction in food intake (Experi-
ments I, V and VI). In contrast, copulation- induced
changes in body weight were not associated with hypo-
phagia. Other reports have shown that sexual activity
can reduce food intake (primarily in young male rats)
90
but that this effect is not necessary for weight re-
duction (Weizenbaum, 1981). Copulation did not sig-
nificantly affect the intake of protein or carbohydrate.
This is in contrast to the findings in Experiment V in
which daily injections of 2 mg TP decreased carbohydrate
intake in castrated male rats compared to carbohydrate
intake of castrated rats receiving injections of .2 mg
TP. In that experiment, both doses of TP increased
protein intake relative to rats treated with the
injection vehicle alone.
Adipose tissue LPL activity is reduced by doses
of TP that decrease food intake, body weight gain
(Experiments I and II) and carcass fat content in
GDX rats. Although the sexually active males gained
significantly less weight than rats in either control
group, adipose tissue LPL activity was unchanged in the
mated animals. These data suggest that copulation-
induced decreases in adiposity (Weizenbaum, 1981) do
not require changes in adipose tissue LPL activity.
Changes in adiposity without alterations in activity
of this enzyme have been observed in female rats (Gray
and Wade
,
1981) .
In summary, although both copulation and testos-
terone treatment may decrease body weight gain and
adiposity, the mechanisms by which they cause such
Changes
.ay differ, whereas high doses of TP
.ay cause
reductions in these measures in part by reducing LPL
activity, copulation-induced changes in weight gain and
carcass fat do not appear to require changes in adipose
tissue LPL activity. There is no evidence, however,
that the reduction in LPL activity in castrated males
treated with high doses of TP is the sole factor
causing decreased weight gain and adiposity; thus, it
is possible that other mechanisms (perhaps similar to
those involved in copulation-induced changes in body
weight) are involved. it is interesting to note that
the levels of circulating testosterone in mated male
rats are dependent upon the frequency of copulation,
such that testosterone levels rise as the frequency of
mating increases (Folman and Drori, 1969). Folman
and Drori (1969) found that male rats allowed to
copulate three times per week to exhaustion had less
body fat than males copulating once a week to ex-
haustion; this latter group had fewer grams of carcass
fat than males allowed to copulate once a week to two
ejaculations. The carcass fat contents of the rats
with the lowest frequency of mating did not differ sig-
nificantly from those of unmated control rats. These
data support the contention that high levels of cir-
culating testosterone decrease carcass adiposity. The
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Changes in body composition that occur after prolonged
periods of cohabitation with females (Drori and Polman,
1964) may, in part, be mediated by sustained increased
levels of endogenous testosterone similar to those pro-
duced by long-term treatment with high doses of TP.
Although other mechanisms by which copulation may
decrease body weight and adiposity are unknown, it is
possible that they might include actions of adrenal
hormones. For example, glucocorticoids promote
mobilization of depot fat and inhibit lipogenesis
(Martin, 1976). That glucocorticoid titers may be
enhanced in mated males is suggested by the observa-
tion that adrenal weights increase with increasing
frequency of mating in male rats (Folman and Drori,
1969). The role of the adrenals (if any) in copula-
tion-induced weight loss awaits further testing.
CHAPTER VI
INVESTIGATION OF
. PROGESTERONE-INDUCED WEIGHT GAIN
IN MALE RATS
Experiment IX: Effects of ProgPsterone_on.Bo^^
Food Intak e and CarcasT^ p^psih i on
in EB- or TP-Treated, GDX rm^ "
Estradiol decreases food intake, body weight and
adiposity in OVX and intact female rats. Progesterone
alone has no effect on any of these measures. How-
ever, when given in conjunction with estradiol, body
weight, eating and adiposity increase (see Chapter I
for references). As discussed earlier, some of the
changes in adiposity seen after treatment with EB or
EB plus progesterone may be mediated by changes in
adipose tissue LPL activity (Wade and Gray, 1979)
.
The effects of these gonadal steroids on adipose tissue
LPL activity are likely mediated via cytoplasmic
estrogen and progestin receptors in female rats (Gray
and Wade, 1979; Wade and Gray, 1978).
In male rats given high doses of TP, the observed
decreases in food intake, body weight and adiposity
(Chapters II and IV) are likely mediated by estrogenic
products of TP. Progesterone given concurrently with
high doses of TP or EB antagonizes the weight-reducing
effects of high doses of TP or EB in GDX males, although
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such treatments do not alter food intake (Gentry and
Wade, 1976a; 1976b)
.
As in female rats, EB treatment depletes cyto-
plasmic estrogen receptors in adipose tissues and de-
creases adipose tissue LPL activity in male rats
(Gray and Wade, 1980). However, unlike its effect in
female rats, EB does not induce progestin receptors in
adipose tissues in male rats, and progesterone does not
affect LPL activity in EB-primed males (Gray and Wade,
1980). The question is therefore raised as to how
progesterone acts to increase body weight in castrated
male rats given either estradiol or repeated injections
of high doses of testosterone.
The purpose of Experiment IX was to investigate
the effects of progesterone on body weight gain and
carcass composition in GDX male rats receiving con-
current injections of EB or high doses of TP. Food
intake was also measured.
Method
.
Animals and housing
. Forty-four adult CD-strain
rats (Charles River Breeding Laboratories) were housed
as in Experiment VIII. Rats were given free access to
Purina rodent chow and tap water, and were castrated
as previously described.
Procedure
.
One month after castration, animals
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each received a daily injection of .1 ml sesame oil for
1 week and baseline food intake and body weight were
recorded. Rats were then matched according to food
intake and body weight and assigned to one of the five
following groups: Oil:
.2 ml sesame oil/day; EB
:
2 yg EB/day; EB + P : 2 yg EB/day + 5 mg progesterone/
day; TP: 2.0 mg TP/day; TP + P: 2.0 mg TP/day + 5 mg
progesterone/day (n = 8 for Oil group, n = 9 all other
groups; Table 9). Hormones were dissolved in sesame
oil and injections were given such that each rat re-
ceived a total volume of . 2 ml daily. Food intake
(including spillage) and body weight were measured
twice weekly.
Carcass analysis
. At the end of the experimental
period animals were killed with an overdose of Nembutal
and prepared for carcass analyses as described in
Experiment V. Carcass analyses were performed as
reported in Experiment V with the exception that lipid
was extracted with 4 x 10 ml petroleum ether.
Data analysis . Data for the week preceding
initiation of hormone injections were used as baseline.
Food intake and body weight data were analyzed as
described in Experiment I except that data were divided
into two 4-week blocks for analysis.
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Results
.
Food intake (Figure 12, Table 9). During the first
four weeks of treatment, food intake was lowest for the
group receiving EB, although the groups did not differ
significantly in amount of food eaten, F (4,39) = 2.44,
£ = .06. Total caloric intake differed across groups
during the final four weeks of hormone treatment,
F (4,39) = 3.57, £<.02. The EB-induced hypophagia
that was evident during Weeks 1-4 was no longer observed
at Weeks 4-8; caloric intake of the EB treatment group
did not differ significantly from that of the oil-
treated control group. Food intake of the group re-
ceiving TP did not differ significantly from either
the EB or Oil group. Whereas food intake was sig-
nificantly increased in the TP + P group compared to
the Oil- or EB-treated rats (£<.05, £<.01, respec-
tively)
,
food intake was not significantly increased
relative to the TP group. Although progesterone treat-
ment also increased food intake in EB-primed rats
during the last month of hormone treatment, this
increase was not significant (compared with either the
EB or Oil group) . In fact, caloric intake of the
EB + P group did not differ significantly from that of
any other group.
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Fig. 12. Effects of EB or a high dose of TP given alone
or given concurrently with progesterone on food intake
in GDX rats.
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TABLE 9
EFFECTS OF PROGESTERONE (P) ON BODY WFTPPtt A.mFOOD INTAKE IN EB- OR TP-^REA^ED RAtI(Mean + S.E.M.
)
GROUP
BODY WEIGHT (q)
BASELINE WEEK 4 WEEK
FOOD INTAKE (kc^l
WEEKS
BASELINE 1-4 5-!
OIL 414.0
+11.3
464.1
+ 11.6
499.5
+11.8
96.9
+ 2.8
95.7
+2.2
95.2
+ 1.5
EB 412.9
+10.6
418.1
+11.8
439.4
+12.6
98.8
+4.2
91.0
+3.2
99.3
+4.8
EB + P 414.6
+10.7
438.2
+ 10.7
463.6
+ 11.7
94.5
+3.7
94.4
+2.7
101.1
+ 3.6
TP 414.0
+11.6
473.1
+ 13.3
495. 6
+13.2
94.3
+3.1
99.4
+2.8
104.5
+ 2.4
TP + P 414.3
+10.8
476.7
+ 13.9
512.0
+ 15.9
94.0
+1.9
102.1
+ 2.8
112.8
+ 3.8
Body weight (Figure 13, Table 9). After four weeks of
injections the treatment groups differed significantly
in body weight gain, F (4,39) =43.41, £<. 00001. Be-
cause groups found to be significantly different
(Newman-Keuls tests) at four weeks were the same groups
that differed significantly at eight weeks, the results
of post hoc comparisons of means at eight weeks will
be given.
Unlike the transient effect of EB on food intake,
EB produced a lasting decrease in body weight. At the
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Fig. 13. Effects of 2 yg EB; 2 yg EB + 5 mg P;
^- 5 mg P; or oil on body weight in GDX rats.
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completion of the 8-week injection period, the Es-
treated group had gained significantly less weight than
either the oil controls or the two TP-treated groups,
F (4,39) = 24.21; £<. 00001 (£<.01, all post hoc tests).
The EB-induced reduction in weight gain was attenuated
by progesterone treatment (£<.05). However, the weight
gain of the EB + P group was still significantly less
than that of the vehicle- treated animals (p<.01; and
it was less than that of either TP treatment group,
£<.01, both tests). Mean body weight gain of the TP
treatment group did not differ significantly from that
of the Oil treatment group. In agreement with the
food intake data, progesterone (which did not signif-
icantly increase caloric intake relative to TP treat-
ment alone) did not significantly increase body weight
gain in TP-treated males. In contrast to the food
intake results, TP + P treatment (which significantly
increased food intake relative to treatment with the
injection vehicle alone) did not significantly increase
body weight compared to Oil-treated controls.
Carcass composition (Figure 14). No significant
differences were found on the percentages of carcass
lipid, protein or water across groups. However, rats
in the TP + P group had significantly more grams of
protein in their carcasses (mean + S.E.M. = 109.5 +
101
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Fig. 14. Carcass composition of GDX rats given
long-term treatment with either EB or a high dose
of TP alone, or EB + P, TP + P, or oil injection
vehicle
.
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4.3 g) than did rats in the EB (93.4 + 3.8 g) group,
F (4,37) = 2.61, p<.05 (2<.05, Newman-Keuls)
. No other
significant differences were found on absolute amount
of carcass protein (mean + S.E.M., oil: 102.7 + 2.5 g;
EB + P: 104.5 4- 3.5 g; TP: 106
. 5 4- 4 . 5 g) . The
TP 4- P group also had significantly more (absolute)
carcass lipid (93.1 + 6.4 g) than did the EB group
(70.0 i 5.0 g), F (4,37) = 2.84, p<.04 (p<.05, Newman-
Keuls). No other significant differences were found
between groups (Oil = 87.6 + 6.7 g lipid; EB + P =
73.3 + 5.8 g; TP = 83.1 + 5.2 g)
.
Experiment X : Effects of TP on Induction of Cvton l ;..c.T.iProgestin Receptors in Epididymal Adipose Tissue in
ADX, GDX Rats "
As stated in Experiment IX, progesterone in-
creases body weight in GDX male rats given EB or high
doses of TP (Gentry and Wade, 1976a; 1976b). However,
EB does not induce progestin receptors in adipose
tissues in male rats. The increased weights of OVX,
EB-treated female rats given progesterone are due
primarily to increased carcass fat contents.
Experiment X was designed to determine whether
a high dose of TP can induce progestin receptors in
adipose tissue in male rats. Experiment IX revealed
that the weight gains of TP-primed, progesterone
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treated males are, in part, due to increased fat con-
tent (although the increased fat content of the TP + p
group was not statistically significant). The present
experiment was conducted prior to the completion of
Experiment IX, at which time it was expected that
progesterone treatment would increase carcass fat in
rats treated with high doses of TP. Thus, at that
time it was of interest to determine whether the in-
crease was mediated via progestin receptors in adipose
tissues
.
Method .
Animals and housing
.
Twenty-seven CD-strain rats
were housed individually, and maintained on a 12 hour
light:12 hour dark cycle (lights on 0600 hr) . Animals
were orchiectomized through a midscrotal incision and
adrenalectomized (ADX) via bilateral dorsolateral in-
cisions. All surgery was done under me thoxyf lurane
anesthesia. Rats were maintained on Purina rodent chow
and 0.9% saline and libitum.
Procedure . One day after surgery, rats were
matched by body weight and divided into three groups
(n = 9 each) . Rats each received a daily injection of
either 2 yg EB or 2 mg TP in .1 ml sesame oil, or
.1 ml of the injection vehicle alone.
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Cytoplasmic progest in receptor assay
. After 10
days of injections, rats were given an overdose of sodium
pentobarbital. Epididymal adipose tissues were rapidly
dissected and weighed to the nearest 0.1 mg . Cyto-
plasmic progestin binding was assayed according to Gay
and Wade's modification of the method of Maclusky and
McEwen (1978) .
Results
.
Neither EB nor TP treatment induced cytoplas-
mic binding sites for the synthetic progestin, 17a,
21-dimethyl-19-norpregna-4
, 9-diene-3 , 20-dione
(R 5020), in epididymal fat in ADX, GDX male rats.
The mean (+ S.E.M.) amount of ["^H]R 5020 specifically
bound for the EB, TP and Oil groups was, respectively,
1.9 + .6 fmol/mg protein; 2.0 + .6 fmol/mg protein, and
2.4 + .9 fmol/mg protein. Differences between groups
were not statistically significant, F (2,25) = .20,
£ = .82.
Discussion
Many of the effects of the various hormone treat-
ments on food intake and body weight gain in Experi-
ment IX are in agreement with findings reported earlier
by Gentry and Wade (1976a; 1976b) . First, EB signif-
icantly decreased weight gain and produced a transient,
statistically nonsignificant reduction in food intake
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in GDX male rats as earlier reported (Gentry and Wade,
1976b). Second, as demonstrated previously (Gentry
and Wade, 1976b), progesterone significantly attenu-
ated EB-induced weight loss without affecting food
intake. Third, daily injections of 2 mg TP initially
increased rate of weight gain in GDX rats, but with
repeated treatment weight gain slowed such that it did
not differ from weight gain of oil-treated rats; where-
as food intake of the TP group did not differ from
that of control animals in any part of the injection
period (as was found by Gentry and Wade, 1976a, but
c.f. Experiments V and VI). In contrast, although
weight gain was greatest in the TP + P group it did
not differ significantly from that of either the TP or
the oil group as it did in the Gentry and Wade study
(1976a)
.
In addition, food intake was significantly
increased in the TP + P group relative to the oil treat-
ment group whereas the food intakes of these two groups
did not differ in the above report.
The lack of effect of TP + P on food intake (com-
pared to oil treatment) reported by Gentry and Wade is
rather surprising since in that study a 1 mg dose of
TP was used. This dose of TP alone increased food
intake compared to oil treatment in one experiment in
that report, although this dose of TP alone apparently
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did not significantly increase food intake in the experi-
ment in which it was also given concurrently with pro-
gesterone. In Experiment IX, an even higher dose of
TP (2 mg), one which reliably does not increase food
intake compared to oil treatment, was used. That food
intake was increased (compared to oil controls) when
progesterone was given in conjunction with the 2 mg
dose of TP is thus all the more striking.
In Experiment ix, as in other experiments, gonadal
hormones sometimes affected body weight without affecting
food intake. As discussed previously (Chapter I; see
also Wade and Gray, 1979), there are data which show
that changes in food intake that follow treatment with
some steroid sex hormones are not always necessary
and/or sufficient to cause the resultant changes in
body weight. The present experiment offers an example
in which food intake was increased without a con-
comitant change in body weight. Food intake of rats
in the TP + P group during the last month of the
experiment increased compared to that of vehicle-
treated animals, whereas body weight gain did not differ
significantly between the groups. Indeed, at the end
of the experiment, the TP + P group was eating 18.5%
more calories daily than was the control group, but
weighed only 2.5% more than the rats in this group.
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The failure to find a difference in body weight between
the oil and TP + p groups may in part be due to the
large weight gain of the oil-treated group. Weight
gains of the oil treatment groups in Experiments V-
VIII and the Oil + Cholesterol control group in
Experiment I ranged from about 10-13% whereas the oil-
treated rats in this experiment gained nearly 21%
above baseline levels.
Estradiol benzoate decreased body weight compared
to controls and analysis of carcass composition revealed
that the weight loss was mainly due to loss of body
lipid. Although progesterone treatment attenuated the
weight-reducing effects of EB, no difference in carcass
composition were found between the EB and EB + P groups.
However, that the percentage of carcass protein was
highest in the EB + P group is of interest in light of
the suggestion by Gray and Wade (1980) that progesterone
may have some anabolic actions in EB-treated male rats.
As in Experiments V and VI, repeated injections
with high doses of TP did not increase weight gain above
the level observed in control animals, and caused a
slight reduction in carcass lipid content (which was
significant in Experiments V and VI, but not in the
present experiment). In rats given 2 mg doses of TP,
progesterone also increased body weight slightly as it
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did in EB-treated rats. The small increase in body
weight was reflected by a slight increase in percent
lipid in the TP + P group. As shown in Figure 14,
progesterone treatment actually reversed the anorexic
effects of high doses of TP on body lipid such that
lipid content of the TP + P and Oil groups appeared
quite similar. That many of the small changes in car-
cass content were not found to be statistically sig-
nificant is likely a result of small sample size and
high variability within groups. Further work is needed
to verify whether the increased lipid content of
progesterone-treated, TP-primed animals (compared to
TP-treated rats) reflects an actual effect of pro-
gesterone or whether it is indeed due to chance.
In agreement with earlier findings, EB did not
induce cytoplasmic progestin binding sites (Gray and
Wade, 1980). Similarly, repeated injections of 2 mg
TP were ineffective in inducing progestin binding sites.
As reported earlier, it is likely that some of the
effects of high doses of TP are mediated via estro-
genic metabolites of the hormone. High doses of TP
deplete cytoplasmic estrogen receptors and decrease
LPL activity in adipose tissues; these effects are
blocked by an aromatization inhibitor (Experiment I)
.
That neither EB nor TP induce cytoplasmic progestin
109
binding sites in adipose tissue in .ale rats suggests
that the small increases in body weight and carcass
adiposity in the TP
. p group are not mediated by
progesterone binding in epididymal adipose tissues.
Progesterone has no effect on LPL activity in EB-
primed male rats (Gray and Wade, 1980). since the
effects of high doses of TP on LPL activity are probably
due to estrogenic metabolites, it is likely that pro-
gesterone has no effect on LPL activity in GDX male
rats given high doses of TP. There are recent data
that show that treatments which fail to induce pro-
gestin binding sites in adipose tissues also fail to
affect LPL activity when given concurrently with
progesterone (Gray and Wade, 1980; 1981).
The mechanism by which TP + p acts to increase
food intake is not known. As before, that TP failed
to induce progestin binding sites in epididymal fat
suggests that TP + p might not affect adipose tissue
LPL activity. Gray and Wade (1981) report that the
nonsteroidal antiestrogen
,
nafoxidine, antagonizes the
induction of cytoplasmic progestin binding sites by
EB in parametrial adipose tissue, and that it has no
effect on adipose tissue LPL when given concurrently
with progesterone. Yet, when nafoxidine is given con-
currently with progesterone, food intake, body weight
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and carcass lipid content increase. These data suggest
that a change in adipose tissue LPL activity is not
the sole mechanism by which progesterone acts to
increase body weight and food intake. m the absence
of any data to the contrary, it is possible that
central mechanisms and/or other peripheral mechanisms
are involved in increasing food intake in GDX male
rats receiving long-term treatment with high doses of
TP plus progesterone.
CHAPTER VII
ABSENCE OF DIETARY EFFECTS ON ANDROGEN-SENSITIVEWEIGHT-RELATED PARAMETERS IN MALE RATS
Experiment XI: Food Intake and Ror^v Weight in R^t^
Two recent studies have found that OVX rats fed
a high fat diet are more responsive to the anorexic
effects of EB than are OVX females fed a standard
chow diet (Young, Nance and Gorski, 1978; Young,
Nance, Gorski and Gordon, 1979). when OVX female rats
fed a high fat or chow diet are each given a single
injection of 6 yg EB , food intake declines significantly
for four days post-injection. However, this decrease
in food intake is significantly greater for rats fed
a high fat diet. Although body weights of both groups
decrease during the post-injection period, the declines
in weights are similar for both groups (Young et al.,
1978) . The hyperresponsiveness of high fat diet fed
females to EB may be specific to food intake since
EB-induced mating behavior is similar in chow or high
fat diet fed rats (Young, Nance, Gorski and Gordon,
1979) . In GDX male rats fed a high fat diet, a single
injection of 6 yg EB decreases food intake, but this
treatment has no effect on food intake in males fed
a chow diet (Young, Nance and Gorski, 1979).
Ill
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In Experiment XI, food intake and body weight were
measured in intact male rats fed chow or high fat diet.
The effect of diet condition (chow or high fat) on the
above measures was also recorded during hormone with-
drawal by orchiectomy.
Method
.
Animals and housing. Sixty adult male CD-strain
rats (Charles River Breeding Laboratories) were housed
individually in wire-bottom cages in a room illuminated
for 12 hours per day (lights on at 2000 hr) . Rats were
maintained on Purina rodent chow until the introduction
of the experimental diets. Tap water was available
throughout the experiment.
Procedure
. Two weeks after their arrival in the
laboratory rats were assigned to one of two groups
(n = 30 each) matched for body weight (Table 10)
.
Groups were high fat diet (HF) and chow diet (C) fed.
At the time of group assignment, food pellets were
removed from the cages of the HF group and were re-
placed by glass bowls containing a high fat diet. This
diet consisted of 2 parts Purina powdered rat chow and
1 part fat (Crisco). The C group continued to receive
Purina rodent chow pellets. The caloric densities of
the diets were: HF = 5.46 kcal/g (Young et al., 1978)
and C = 3.61 kcal/g (Corbit and Stellar, 1964).
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Animals were allowed 1 week to adapt to the diets.
Food intake (to the nearest .1 gram; spillage accounted
for) and body weight (to the nearest gram) were measured
twice weekly after diet adaptation. After two weeks of
post-baseline data collection rats were orchiec tomized
under me thoxyflurane anesthesia through a single scrotal
incision. Data were collected for 6 weeks post-
castration
.
Data analysis. Food intake data were converted
to k calories. Data were divided into three 3-week
blocks (baseline and Weeks 1-2 = pre-gonadec tomy
;
Weeks 3-5 and Weeks 6-8 = pos t-gonadec tomy ) . A con-
trol group to assess the effects of surgery alone was
not included in the experiment. However, Gentry and
Wade (1976a) found the effects of surgery on food
intake and body weight to be limited to the first 3 to
6 post-surgical days. Thus, to minimize the possi-
bility that the decreases reported in the section that
follows were due to surgical trauma alone, statis-
tical analyses of data from the first 3-week block
following orchiectomy were not included in the results.
Comparisons between groups (diets) were analyzed with
Student's t-test; within group comparisons were made
using a t-test for paired observations. A £ value
<,05 (two-tailed) was considered significant.
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Fig. 15. Effect of castration on body weight
rats fed chow or high fat diet.
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Results
.
Body weight (Figure 15, Table 10). The rate of
weight gain was not affected by diet. However, castra-
tion significantly decreased the rate of weight gain
(rate of gain pre-gonadectomy versus rate of weight
gain Weeks 6-8; C: t = 11.56, p<.0001; HF: t =
-29
10.92, p<.0001). During the three weeks prior to cas-
tration, the rates of weight gain for the C and HF
groups were, respectively, 1.4 + .05 g/day and
1.5 + .1 g/day. The rates of weight gain for the C and
HF groups during Weeks 6-8 were, respectively, .65 +
.07 g/day and .80 + .07 g/day.
Food intake (Figure 16, Table 10). At the start
of the experiment food intake did not differ signif-
icantly between groups (mean + S.E.M.; C: 112.3 +
1.6 kcal/day; HF : 107.5 + 2.8 kcal/day, t^^ = 1.48,
£>.l). However, by Week 2 (three weeks on experimental
diets) the HF group (mean + S.E.M. = 103.0 + 2.4 kcal/
day) was eating significantly less than was the C
group (112.4 + 1.5 kcal/day; t^g = 3.34, 2<.01).
Total daily food intake during the three weeks prior
to castration (baseline and Weeks 1 and 2) was signif-
icantly less for the HF diet fed rats than for the C
fed rats (t^g = 2.44, p<.02). Total food intake remained
lower for the HF group than the C group throughout the
116
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Fig. 16. Effect of castration on caloric intake in
male rats fed chow or high fat diet.
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TABLE 10
(Mean + S.E.M.
)
o — 8
GROUP
CHOW
HIGH FAT
447.6
+ 5.8
447.6
+ 6.9
523.9
+ 7.0
524.7
+ 11.4
112.3
+ 1.4
105.3
+ 2.5
106.8
+ 1.6
103.0
+ 1.5
100.6
+ 2.9
93.1
+ 2.6
post-castration period (Weeks 6-8; t^^ = 3.25, £<.01).
Castration significantly decreased food intake in both
groups (Weeks 6-8; C: t^^ = 8.31, £<.0001; HF : t^g =
8.14, £<.0001)
.
Experiment XII: Food Intake and Body Weiaht
in GDX Rats Fed Chow or High Fat DleFT—
Effects of Testosterone Replacement
As discussed in Experiment XI, male or female rats
fed a high fat diet are hyperresponsive to the hypo-
phagia-inducing effect of EB. In the present experiment
GDX male rats, each receiving a daily injection of
either a high or low dose of TP, were fed chow or high
fat diet and body weight and food intake were recorded.
If high doses of TP decrease food intake (relative to
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treatment with a lower dose of TP) via aromat i zat ion
to estrogens, then male rats fed a high fat diet and
treated with high doses of TP should eat less than
similarly treated rats fed chow.
Method
.
Procedure. Rats were those used in Experiment II.
Six weeks after castration, rats within each diet con-
dition were assigned to one of three hormone treatment
groups (n = 10 each) matched for body weight and food
intake (Table 11). Rats each received a daily injec-
tion of either 2 mg TP,
. 2 mg TP or .1 ml of the in-
jection vehicle alone. Hormones were injected in . 1 ml
sesame oil. Food intake (including spillage) and body
weight were recorded twice weekly. After six weeks of
injections, rats were killed with an overdose of
Nembutal and anal-nasal lengths were recorded for Lee
Index measurements (body we ight° * ^^/nasal-anal length;
Lee, 1928) . Values reported for the Lee Index = Lee
Index X 1000 (Table 11)
.
Data analysis
.
Body weight data were converted
to percent baseline and food intake data were converted
to k calories. Data were analyzed using a 2 x 3
factor (Diet x Hormone Treatment) analysis of variance
(Winer, 1962). Although no significant Diet x Hormone
Treatment interactions were found, significant main
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effects of Hormone Treatment (p<.05) were followed by
Newman-Keuls tests to determine whether both doses of
TP were equally effective in influencing the dependent
variable at one category of diet (Winer, 1962).
Results
.
Body weight (Figure 17, Table 11). At the start
of hormone injections, groups did not differ signif-
icantly on body weight. After three weeks of hormone
treatment, rats eating the HF diet had gained signif-
icantly more weight than had the C fed rats, F (1,54) =
4.86, p<.05. At Week 3, the groups receiving low doses
of TP had gained significantly more weight than those
receiving the higher TP doses or the oil vehicle alone,
F (2,54) = 24.71, £<.0001 (£<.01, both diet conditions),
and the high dose TP groups weighed more than the oil
control groups (£<.01, both diet conditions). At the
end of the experimental period (Week 6) the two diet
groups did not differ significantly on body weight gain,
F (1,54) = 3.34, p>.07. However, as during the first
half of the treatment period, body weight gain was sig-
nificantly higher in the low dose TP groups than in the
high dose TP or oil groups, F (2,54) = 31.45, £<. 00001
(£<.01, all post hoc tests, both diet conditions).
Whereas the HF fed 2.0 mg TP group gained significantly
more weight than the HF fed, vehicle-treated rats
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Fig. 17. Effect of long-term treatment with a
high or low dose of TP on body weight in GDX
rats fed high fat (top) or chow (bottom) diet.
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(£<.05), c fed rats receiving the high dose of TP did
not differ significantly from the vehicle- treated con-
trol group.
Food intake (Figure 18, Table 11). At the
beginning of the injection period, rats fed the HF diet
were eating significantly less than were C fed rats,
F (1,54) = 5.95, £<.02. No other differences across
groups were found on baseline intake measures. During
the first three weeks of hormone treatment, rats fed
the C diet consumed significantly more calories than
did the rats eating the HF diet, F (1,54) = 6.11,
£<.02. No significant Hormone or Hormone x Diet
interaction effects were found at this time (F (2,54)
= .936, £>.39; F (2,54) = .709, £>.49, respectively).
During the final three weeks of the experiment, food
intake of HF fed animals was still significantly lower
than that of C fed rats, F (1,54) = 17.06, £<.0001.
However, during this last half of the experimental
period (unlike the first half) , a significant Hormone
Treatment effect was found, F (2,54) = 10.19,
£<.0001. Both doses of TP significantly increased food
intake compared to oil controls (£<.01, C fed;
£<.05, HF fed). Caloric intakes of the 2.0 mg TP
groups did not differ significantly from those of the
low dose TP groups.
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Fig. 18. Effect of long-term treatment with ahigh or low dose of TP on caloric intake of GDX ratsfed high fat (top) or chow (bottom) diet.
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Lee index. Lee index measurements are given in
Table 11. Analysis of variance revealed a significant
main effect of Diet, F (1,54) = 11. is, p<.ooi, whereas
no effect of Hormone Treatment (F (2,54) = 1.22, £>.29)
and no Diet x Hormone Treatment interaction was found
(F (2,54) = .88, £>.4). Thus, although body weights of
HF and C fed rats did not differ at the end of the
experiment, rats fed the HF diet were fatter than C fed
rats
.
Discussion
In male rats, the rates of weight gain following
castration were not affected by diet. In agreement with
earlier findings, orchiectomy decreased the rate of
body weight gain (in chow fed rats; Gentry and Wade,
1976a)
.
Whereas food intakes did not differ between
groups during the first week on the experimental diets
(baseline)
, total food intake for the HF group fell
significantly below that of the C group during the
remainder of the experiment. A decrease in caloric
intake compared to initial intake has been reported
previously for female rats fed a HF diet (Corbit and
Stellar, 1964). That the decrease in food intake in
HF diet fed males (compared to C fed rats) was a
response to the HF diet and not due to castration is
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supported by the fact that males consuming the HP diet
still maintained their intakes at levels lower than
those Of c fed males when replacement hormones were
given. In the present experiment, castration signif-
icantly decreased food intake in rats in both diet
groups. This is in contrast to the findings of Young,
Nance and Gorski (1979) who reported no effect of
castration on food intake in HF fed male rats. m that
study male rats fed a HF diet consumed a significantly
greater number of calories than did C fed rats.
It was predicted that food intake of HF diet fed
rats receiving the high dose of TP would be decreased
relative to that of rats receiving similar hormone
treatment and fed a C diet. The above decrease would
be expected to occur after about two weeks of hormone
treatment since it is at this time that the estrogenic
effects of high doses of TP on body weight gain are
observed. in Experiment XII, no evidence was found to
suggest that HF fed rats treated with high doses of
TP were hyperresponsive to the effects of estrogenic
metabolites of TP compared to similarly treated males
fed the C diet. That is, no Diet x Hormone Treatment
interaction was found during any period of hormone
administration. In addition, individual comparisons
(t-tests; data not shown) on the percent change in food
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intake from baseline levels at each week of hormone
treatment for the HF and C fed rats receiving injections
of 2.0 mg TP revealed no significant differences be-
tween groups at any time. The present results do,
however, replicate previous findings on the effects of
.2 mg and 2.0 mg doses of TP on food intake and body
weight gain in GDX, C fed rats (Experiment I; Gentry
and Wade
, 1976a)
.
It is not known why high doses of TP failed to
suppress food intake in HF fed males compared to C fed,
2.0 mg TP-treated rats. Chow fed, GDX male rats are
relatively insensitive to the influences of EB on
food intake compared to female rats (Gentry and Wade,
1976b; Young, Nance and Gorski, 1979). Young, Nance
and Gorski (1979) , found that one injection of EB sup-
pressed food intake in HF fed GDX males, whereas this
treatment did not reduce food intake in C fed animals.
In that experiment the rats eating the HF diet ate
significantly more prior to hormone treatment
(103.9 kcal/day) than did the C fed animals (86.9 kcal/
day)
. It is possible that this effect of estrogen is
only manifest when food intake of HF fed rats is
initially higher than that of C fed rats.
It is interesting to note that the HF diet fed
rats ate significantly fewer calories throughout the
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experiment compared to C fed rats vet- hof-v.idcb, y t both groups gained
weight at similar rates Thi<^ fi^^ni-dte . ihis finding may possibly be
explained by examining the metabolic costs for storage
of the different dietary components contained in each
diet. Since rats in both diet groups were gaining
weight, it may be assumed that the amounts of food con-
sumed exceeded the animals' immediate caloric require-
ments and excess fuels were stored for later use (see
Friedman and Strieker, 1976 for review). The C diet
contained approximately 22.8% protein, 4.5% fat and
56% carbohydrate (or about .9 kcal/g and 2.3 kcal/g C
diet, respectively). The percentages of protein, fat
and carbohydrate for the HF diet were, respectively,
15.3% (.6 kcal/g HF diet), 36.3% (3.3 kcal/g) and 37.3%
(1.5 kcal/g). Flatt (1978) has estimated that the dis-
sipation of energy through storage (including allowance
for recycling) is 24% for protein, 7% for fat, and 4%
and 28% for carbohydrate when it is stored, respectively,
as glycogen or fat. From the estimations above, it is
suggested that less energy was required to store the
HF diet than the C diet, and thus rats eating the HF
diet could consume fewer calories than the C fed rats
and still maintain a similar level of body weight.
It is not my intention to imply that the above
analysis of metabolic energy expenditure is by any
means complete. However, that rats fed the HF diets
stored
.ore calories as fat (and fat provided the majority
Of calories in the diet and required relatively little
energy for direct storage in adipose tissues) is sug-
gested by the significantly higher Lee index ratings
of the HF group compared to the C groups. m fairness,
it Should be stated that there is disagreement in the
literature as to whether the Lee index provides a good
measurement of obesity (increased body fat; e.g.,
Bernardis and Patterson, 1968; but c.f. Stephens, 1980).
Earl Simson (manuscript in preparation, 1981) has data
which suggest that the Lee index correlates well with
dietary-induced increases in body fat, but not with
hormone-dependent (e.g., OVX-induced) obesity. m
Experiment VII, nasal-ano lengths were recorded for Lee
index measurements in addition to determination of body
fat content by direct carcass analysis. Indeed, in
that experiment, the correlation between percent carcass
lipid and the Lee index rating was only .42, although
the mean Lee index rating for each hormone treatment
group showed the same direction of change as the mean
percent lipid for each group. (The mean (+S.E.M.) Lee
index and the mean (+S.E.M.) percent wet carcass lipid
for the treatment groups were, respectively: Oil -
317.5 + 2.7, 21.9 + .8%; 2.0 mg DHTP - 319.8 + 2.4,
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22.2 + .8%; 0.2 mg DHTP - 320.7 + 3.0, 22.1 +
.8%).
In summary, no evidence was found to suggest that
male rats fed a high fat diet are hyper respons ive to
the anorexic effects of estrogenic metabolites of
testosterone. High fat and chow fed GDX rats responded
similarly to androgen replacement therapy in terms of
body weight and food intake, although the daily caloric
intake of rats fed the high fat diet was consistently
lower than that of rats eating standard laboratory
chow.
CHAPTER VIII
GENERAL DISCUSSION
Major Findings
Castration of male rats significantly decreases
food intake and body weight gain (Experiment XI). when
castrated male rats are given long-term treatment with
.2 mg TP, food intake and body weight gain increase
compared to GDX rats receiving the injection vehicle
alone (Experiments I, v, vi
, xil) . This dose of TP
(200 yg/day) has been shown to restore circulating
plasma testosterone titers to pre-cas tration levels
in adult orchiectomized male rats (Patsch, Kim, Wiest
and Schonfeld, 1980). The increased food intake of
GDX rats given daily injections of this relatively
low dose of TP is, in general, due to enhanced con-
sumption of all dietary components (Experiments V and
VI)
.
Postmortem carcass analyses revealed that the
increased body weight of the .2 mg TP-treated group was
associated with elevated carcass protein content com-
pared to the GDX, oil-treated group (Experiment VI).
Low doses of TP not only increase carcass protein (on
a per gram basis), carcass lipid is also significantly
increased by this treatment compared to oil or high
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aose TP treatment.
..^3 increase in fat eXea.l,
.ot
aue to Changes in LPL activity i„ epidiay^al adipose
tissue (Experiment II,. some o£ the increased fat of
n-ales treated with low doses of TP may be due to in-
corporation Of lipi,3 into muscle durin, TP-stimulated
Muscle growth. However, there is virtually no in-
formation on other mechanisms which increase adiposity
in male rats. Little information is available on the
influence of testosterone on enzymes involved in
triglyceride storage and clearance in rats, with the
exception of one study which found a sex difference in
hepatic apoproteins that is controlled by testos-
terone (Patsch et al., 1980), no studies have system-
atically investigated the effects of castration and
androgen replacement on triglyceride metabolism in
male rats.
When GDX male rats are treated with higher doses
of TP (1 or 2 mg/day) body weight gain and food intake
initially increase such that they generally do not
differ significantly from those of GDX rats given
daily injections of .2 mg TP (Experiments I, V, VI,
XII). However, after approximately one week, body
weight gain and food intake of rats receiving the
higher doses of TP begin to decrease relative to those
of rats given the lower concentrations of TP. After
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one to two months of treatment with high doses of TP,
body weight has fallen such that it is significantly'
lower than that of rats treated with .2
.g doses of TP
(Experiments I, V, VI, xil) ; and it is similar to (and
not significantly different from) weight of oil-treated
controls (Experiments I, v, ix, XII). On the other
hand, rats given high doses of TP show a transient
decrease in food intake (relative to .2 mg TP-treated
rats), but with extended treatment food intake increases
such that it does not differ significantly from that
of rats given lower doses of TP (Experiments I , vi
,
XII). Note, however, that when rats were allowed to
self-select from two isocaloric diets differing in
protein and carbohydrate contents (Experiment V) total
caloric intake was significantly higher in .2 mg TP-
treated rats than in rats given 2.0 mg doses of TP.
Food intake of rats given long-term treatment with high
doses of TP is higher than that of oil-treated rats
(this increase was significant in Experiments V, VI and
XII, but not in Experiments I or IX).
Treatment with the 2.0 mg dose of TP causes a
selective increase in protein intake. Protein intake
of GDX rats treated with high doses of TP does not
differ from that of rats given .2 mg TP (Experiments
V and VI)
. These data support the contention that the
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increased food intake of chow fed rats given high doses
of TP actually reflects an attempt to acquire a greater
quantity of a specific macronutr ient
, protein. indeed,
total caloric intake of self-selecting GDX rats given
high doses of TP was significantly less than that of
self-selecting rats given .2 mg doses of TP. The
elevated protein intake of rats treated with 2.0 mg
doses of TP was associated with increased carcass
protein content (as it was in rats given lower doses
of TP)
.
The decreased weight of rats treated with the
high dose of TP is due to a reduction in body fat
content (Experiment VI).
Data have been presented which strongly suggest
that both the decreased body weight and adiposity of
GDX male rats given extended treatment with high doses
of TP are due to estrogenic metabolites of TP (Experi-
ments I and II). First, concurrent treatment with ATD,
which blocks the aromatization of androgens to estro-
gens, prevents the weight-reducing effects of high doses
of TP. Second, long-term treatment with high (1.0 mg/
day), but not low (.2 mg/day) , doses of TP depletes
cytoplasmic estrogen receptors in male rat adipose
tissues, possibly by causing translocation of the
receptor-hormone complexes into cell nuclei. Gray,
Dudley and Wade (1981) have demonstrated an
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accumulation of radioactivity in nuclei of adipose
tissue cells following an injection of [\]estradiol
in GDX male or female rats. The estrogen specificity
of the receptor depletion in the high dose TP-treated
males is demonstrated by its absence in rats given
simultaneous treatment with 1 . 0 mg doses of TP and
the aromatization inhibitor, ATD. Third, repeated
daily injections of 1.0 mg TP (but not .2 mg TP)
reduce LPL activity (by approximately 60%) in
epididymal adipose tissues. A similar (75%) reduction
in adipose tissue LPL activity is observed following
EB treatment in GDX male rats (Gray and Wade, 1980).
Again, the effects of high doses of TP on epididymal
adipose tissue LPL activity are blocked by concurrent
treatment with ATD. Finally, injections of the non-
aromatizable androgen, DHTP, increase (but do not
decrease)
,
food intake and body weight gain, even when
given in high doses (Experiment VII). These data sup-
port the hypothesis that aromatized metabolites of
testosterone may, in part, reduce body weight and
adiposity by direct actions on adipose tissue metab-
olism, including LPL activity. Thus, estrogenic
metabolites of testosterone affect body weight and
adiposity by a mechanism similar to that by which
estrogens affect changes in these variables in female
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rats. In addition, estrogenic metabolites of TP may
also act at central (hypothalamic) sites to decrease
food intake in male rats (Experiments in and IV)
, just
as hypothalamic implants of eb reduce food intake in
female rats.
Although data above provide support for the
hypothesis that reductions in body weight and
adiposity that follow treatment with high doses of
testosterone are due to aromatized metabolites of the
androgen, they do not explain why a lag period exists
between injections of the hormone and the observation
of decreases in these measures. That is, in rats
given daily injections of 2.0 mg doses of TP, body
weight increases for approximately one week, and it
is only after this time that the attenuation in weight
gain is observed. This question cannot be answered
directly since although it is known that human adipose
tissues contain the enzymes necessary for aromatiza tion
of androgens to estrogens (Kley et al., 1980; Nimrod
and Ryan, 1975; Perel and Killinger, 1979), inves-
tigators have not yet attempted to measure aromatase
activity in adipose tissues in rats. The role played
by gonadal steroids in regulation of aromatase activity
in human adipose tissue is not known.
Nonetheless, one explanation for the seven to ten
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day lag period
.ay be that testosterone titers
.ust be
elevated above normal (unmated) circulating levels for
an extended period of time in order to induce aro.atase
activity that is sufficient to override the weight-
increasing effects of testosterone. m the central
nervous system, castration decreases and androgens in-
crease aromatase activity in rats (Kobayashi and Reed,
1977). The temporal requirements for induction of
aromatase activity by testosterone have not been system-
atically studied. However, there is evidence that under
certain circumstances in human males, prolonged admin-
istration of testosterone is necessary to induce
aromatase activity in some systems. For example, acute
testosterone treatment does not affect pituitary
responsiveness to gonadotropin-releasing hormone
(GnRH)
.
However, after two to four weeks of testos-
terone treatment, pituitary responsiveness to GnRH
decreases sharply, just as it does following short-term
estradiol treatment (Bardin, 1980). The apparently long
lag period for induction of a specific protein by tes-
tosterone is not unprecedented. The hepatic protein,
^2u~^'^^^^-^^^' found in adult male rats, but is absent
in adult females. Castration decreases a2^-globulin in
males, and testosterone treatment of GDX male or female
rats induces a2|_j-globulin to levels near those of intact
:ion-
m
-ale rats after eight days (Bardin and Catterall, 1981).
AS discussed more fully in Chapter V, copulat
induced reductions in body weight
.ay be mediated by
mechanisms other than those mediating the decreases
weight that follow prolonged treatment with high doses
Of TP in castrated rats. Body weight gain was decreased
in rats allowed to copulate, but this decrease was not
associated with changes in caloric intake or in the in-
take of specific nutrients. Furthermore, LPL activity
in epididymal fat depots was not altered in mated male
rats (Experiment VIII). Several researchers have re-
ported that copulation increases plasma testosterone
and luteinizing hormone (LH) levels (Graham and
Desjardins, 1980; Kamel and Frankel, 1978; 1979; Kamel
et al., 1975). in contrast, Balin and Schwartz (1976)
failed to find increased plasma LH in mated male rats
(even when serum sampling took place every 15 minutes
during the hour following completion of mating tests),
yet rats in that study had significantly higher seminal
vesicle weights than unmated males (testosterone was
not measured)
.
The results of Experiment VIII suggest
that the reduced body weights of mated male rats are
not mediated solely by testicular testosterone. Further
work is needed to ascertain whether the changes in
adiposity and body weight of males given unlimited access
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to receptive fe.ales are mediated by sustained increased
levels of endogenous testosterone. Unfortunately, it is
not known if repeated injections of 2.0 mg TP/day
produce plasma testosterone titers similar to the cir-
culating levels of testosterone in intact male rats
housed with females.
Summary and Conclusions
Testicular steroid hormones exert marked effects
on food intake, body weight and carcass composition in
male rats. Some information exists on mechanisms by
which androgens affect the latter two variables, but
the evidence suggesting how these hormones influence
food intake is scarce. Food intake and body weight
gain do not always change in parallel as would be ex-
pected if weight gain directly reflected food intake
(e.g., Experiment I). Provided below is a scheme
which summarizes how androgens may influence the above
measures in male rats (some of the influences of
testosterone on eating and body weight are summarized
in Figure 19)
.
It should be cautioned that this view
is admittedly (and necessarily) derived from a limited
group of data and is incomplete; but as stated by George
Wade, whose work has contributed greatly to an under-
standing of how gonadal hormones affect food intake,
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body weight and adiposity in rats: "m the absence of
data, one is free to speculate."
Testicular hormones may act at several sites. Two
target sites are the hypothalamus and pituitary which
contain steroid-specific, saturable cytoplasmic estrogen
(Eisenfeld, 1970), progestin (Kato and Onouchi, 1977;
Maclusky and McEwen, 1978) and androgen receptors
(Barley et al., 1975; Naess, Attramadal and Aakvaag,
1975)
.
The hormone-receptor complexes are concentrated
in cell nuclei and alter both RNA and protein synthesis
(Blaustein and Wade, 1978; Lieberburg and McEwen, 1977;
Zigmond and McEwen, 1970)
.
Androgens may exert several central effects,
primarily via the hypothalamus. That testicular hormones
induce aromatase activity in several hypothalamic sites
is shown by the finding that castration reduces
aromatase activity in specific hypothalamic nuclei to
levels observed in female rats (Kobayashi and Reed,
1977). Thus, androgens, primarily testosterone, and its
estrogenic metabolites, may act in several of the
following ways. First, the hormones might exert direct
effects on eating behavior. As has been demonstrated,
VMH implants of TP or EE decrease food intake in male
rats (Beatty et al., 1974; Experiments III and IV).
However, it is not known if the change in food intake
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is by direct neural control of ingestive behaviors.
Second, hormones may act in the hypothalamus to
influence metabolism via the autonomic nervous
system. For example, the hypothalamus has been shown
to influence the endocrine pancreas via autonomic
nerves (Woods and Porte, 1974). Testosterone might
influence the hypothalamus to increase insulin
secretion, thus increasing body weight. However, this
cannot be the only mechanism by which androgens act,
since the anabolic effects of testosterone are un-
altered in castrated alloxan-diabetic male rats
(Kochakian, 1975). Carcass fat was not measured in
that study, but testosterone increases adiposity and
nitrogen retention in GDX, diabetic male dogs (Kochakian,
1975) . Third, testosterone and estradiol could exert
indirect effects on metabolism by influencing hypo-
thalamic releasing hormones. For example, estradiol
increases plasma prolactin in male rats (Tresguer res
,
Esquif ino, Perez Mendez and Lopez-Calderon
, 1981)
,
and prolactin decreases adipose tissue LPL (Zinder,
Hamosh, Fleck and Scow, 1974), as does estradiol.
Furthermore, prolactin acts synergistically to poten-
tiate the effects of testosterone in muscle and in
male reproductive tissues (Bardin, 1980; Mainwaring,
1978) .
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Gonadal hormones may also act directly on the
pituitary. Testosterone, for example, may act at the
pituitary (and/or hypothalamus) to influence secretion
of growth hormone. Growth hormone has anabolic actions
similar to those of testosterone, and it has also been
shown to stimulate food intake (Kochakian, 1975; Martin,
1976). However, that the effects of testosterone are
not mediated by growth hormone is evidenced by the fact
that testosterone influences these measures in hypophy-
sectomized male rats (Kochakian, 1975). m addition,
the concurrent administration of testosterone and
growth hormone produces an additive effect on nitrogen
retention and body weight gain (Kochakian, 1975).
Thus, in addition to direct actions on behaviors,
testicular hormones may act in the central nervous
system and pituitary to bring about metabolic changes
which, in turn, indirectly influence food intake, body
weight and carcass composition. Testosterone may also
affect secretion of certain pituitary hormones which
potentiate the effects of the steroid.
Testicular estrogens or estrogenic metabolites of
testosterone formed locally, may also act directly on
adipose tissues via cytoplasmic estrogen receptors (Wade
and Gray, 1978) to reduce LPL activity. The reduction
in enzyme activity may decrease body weight and
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adiposity and result in increased availability of tri-
glycerides as utilizable fuels for use in other tissues.
Altered fuel levels could consequently change food in-
take, but as discussed earlier, information concerning
hormonal effects on triglyceride metabolism in male
rats is virtually nonexistent.
Finally, androgens have growth-promoting effects
on many peripheral tissues containing androgen-binding
proteins. Testosterone has anabolic effects on tissues
such as skeletal muscle and kidney (Bardin et al., 1978;
Kochakian, 1975; Scow, 1952). Anabolic actions in
liver appear to be mediated by the testosterone
metabolite, androstenedione (Gustafsson, Pousette,
Stenberg and Wrange, 1975; Mainwaring, 1978). Tes-
tosterone and DHT stimulate growth in male reproductive
tissues
.
In summary, androgens may act at multiple sites
to alter food intake, body weight and carcass com-
position in male rats. The work presented in this
dissertation investigated some of the sites at which
androgens act and some mechanisms by which they act
to influence these variables.
"Oyf itlekhn terets ken men gefinen a naye kashye."
(There is a new question to every answer.)
Old Yiddish Proverb
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